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Abstract 
        Articular cartilage lines the ends of bones, provides low friction and load bearing, and 
allows for efficient joint movement. Once damaged, articular cartilage has difficulty of repairing 
itself due to lack of blood and nerve supply. Cartilage tissue engineering (CTE) aims to provide 
solutions to cartilage defects and involves the use of cells, scaffolds, and stimulating factors, 
alone or in combination. Hydrogel, a crosslinked polymeric network containing large amounts of 
water, is regarded as the ideal scaffolding material for CTE due to its structural similarity to 
native cartilage. Encapsulating chondrocytes in hydrogels is a promising approach to provide 
high cell seeding density, uniform cell distribution and a suitable microenvironment for 
encapsulated chondrocytes. However, fabrication of hydrogel scaffolds with desired 
microstructure/internal structure and living cells is the key issue, which limits hydrogel’s 
applications in cartilage tissue engineering. To address these issues, this thesis aimed to bioprint 
cartilage constructs that incorporate living cells and characterize them in vitro for CTE. This aim 
was achieved via pursuing the following three specific objectives. 
        The first objective was to fabricate CTE scaffolds based on the bioprinting technique and to 
study the influence of scaffold design on the mechanical performance. Gelatin and alginate 
mixtures were synthesized and printed into porous hydrogel scaffolds with the help of 
thermal/submerged ionic crosslinking process. The scaffold geometries, including stand 
orientation and the spacing between them, were adjusted for bioprinting and their influence on 
the scaffold mechanical properties were investigated. Results showed that there was a significant 
influence of internal design on the mechanical performance of printed hydrogel scaffolds and 
porosity, contact area between strands and spacing variation were three key factors that influence 
the mechanical performance of scaffolds.  
        The second objective was to develop a 3D Bioplotting technique or process supplemented 
with the submerged cross-linking mechanism to fabricate alginate hydrogel constructs with 
living cells. In vitro biological performance of the printed alginate constructs was evaluated in 
terms of cell viability, proliferation and secretion of sulfated glycosaminoglycan (GAG) and 
Collagen type II.  Chondrocytes were homogeneously distributed in the bioprinted hydrogels and 
cell viabilities were around 80%. Cartilage extracellular matrix (ECM) including 
glycosaminoglycan (GAG) and Collagen type II were synthesized by embedded chondrocytes, 
demonstrating the promising biocompatibility of this bioprinting technique. 
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        The third objective was to test the hypothesis that homogeneously dispersed hydroxyapatite 
in alginate hydrogel promotes the formation of calcified cartilage matrix. Cell growth, 
extracellular matrix (ECM) production, and mineralization potential were evaluated in the 
presence or absence of hydroxyapatite particles for comparison. The hydroxyapatite (HAP) 
phase was evenly dispersed into alginate hydrogel with the addition of a surfactant-sodium 
citrate (SC). Chondrocytes embedded in this composite hydrogel demonstrated expression of 
alkaline phosphatase (ALP) after 14 days of culture. Characteristic ECM in calcified cartilage 
such as minerals and Collagen type X showed a significantly higher synthesis in composite 
hydrogels with pre-incorporated HAP than that of alginate hydrogels. These results provided 
researchers with a facile technique to bioprint porous chondrocyte-laden hydrogel constructs for 
application in CTE and demonstrated a technique of inducing chondrocytes to synthesize 
calcified cartilage matrix by simply mixing HAP into hydrogel.  
       Taken all together, this thesis presented the techniques/methods developed to bioprint 
cartilage constructs with living cells and would bring forward the fabrication of constructs for the 
repair of cartilage defects.  
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Chapter 1: Introduction 
 
1.1 Articular Cartilage Defects and Osteoarthritis 
        There are three major types of cartilage existing in human body, hyaline cartilage (found in 
the elbows, hips, knees, sternum and rib cage), fibrocartilage (found in intervertebral discs) and 
elastic cartilage (found in the external ear, epiglottis). This thesis will focus on the regeneration 
of articular cartilage, a type of hyaline cartilage. Articular cartilage (AC) is a thin layer of highly 
hydrated and specialized tissue that lines the ends of diarthrodial joints and functions to provide 
a low-friction, wear-resistant, and load-bearing surface for efficient joint movement (1, 2). 
Besides water (70-80% by total weight), the solid fraction of mature articular cartilage is made 
up of collagens (50-75%), proteoglycans (15-30%) with the remaining composition including 
chondrocytes and other minor protein molecules. Collagen type II is the major collagen type in 
articular cartilage, comprising more than half the dry weight of the tissue. Articular cartilage also 
has globular and fibrillar collagen types, like Collagen types V, VI, IX, and XI (3). Although the 
roles of these collagen types are yet fully understood, they are believed to play a key role in 
modulating the structure of collagen type II and intermolecular interactions (4). For instance, 
Collagen type IV is mainly found in the pericellular matrix and probably contribute to regulate 
interactions between the chondrocyte and extracellular matrix (ECM) (5, 6). Collagen type X, 
mainly found in the calcified cartilage, seems to play a role in building an interface between 
cartilage and the subchondral bone (7). The primary proteoglycan in articular cartilage is 
aggrecan, consisting of a protein core and sulfated GAG side chains. Other types of 
proteoglycans in articular cartilage include biglycan, lubricin, fibromodulin, which are also 
comprised of core proteins with various glycosaminoglycan species attached as side chains (8). 
Many proteoglycans grouping into large macromolecular complexes is critical for the 
functionality of cartilage tissue. An integrated network is formed by collagens and proteoglycans 
that lay the foundation for the distinct mechanical performance of articular cartilage (9).  
        Although the thickness of articular cartilage is no more than several millimeters (10), it is 
divided into four zones, i.e., superficial zone, middle zone, deep zone, and calcified zone, based 
on the morphology and composition of its components. In superficial zone, densely packed 
collagen fibers are oriented parallel to the cartilage surface and proteoglycan content is relatively 
low. Chondrocytes exhibit discoidal, flattened shapes (11). In middle zone, collagen fibers are 
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randomly oriented and proteoglycan content reaches its maximum. Chondrocytes show spherical 
shape with a much lower density than superficial zone (11). In deep zone, collagen fibers are 
oriented perpendicular to the articular surface and proteoglycan content is much lower than 
middle zone. Chondrocytes are grouped in a columnar organization with the lowest density 
compared with any other of zone in articular cartilage (11). Below these zones is the calcified 
cartilage. In calcified cartilage, hypertrophic chondrocytes are embedded in a mineralized matrix. 
It not only facilitates cartilage-to-bone integration but also serves as a physical barrier that 
enables pressurization of articular cartilage. This barrier is important for maintaining the 
integrity of repaired cartilage and thus, successful regeneration of the calcified cartilage layer 
essential for functional cartilage repair. Underlying calcified zone is the subchondral bone (12-
14). 
        Articular cartilage injury is common and its pathogenesis is multifactorial (15). It can be 
caused by sports, trauma, obesity, and lack of movement (16). Once damaged, articular cartilage 
has difficulty repairing itself due to its avascular and aneural nature (16). Depending on the 
depth, cartilage defects can be categorized into two types: chondral defects and osteochondral 
defects (17). Chondral defects do not extend to the subchondral bone and patients will not feel 
any pain due to its aneural nature (18). Meanwhile, tissue self-repair is insufficient because of 
lack of vascular network. This may lead to the eventual development of osteochondral lesions, 
which will penetrate into subchondral bone (19). In this case, progenitor cells from bone marrow 
are recruited to fill and regenerate the defects with impaired functionality (20). The regenerated 
tissue is mainly fibrocartilage, which results in an inferior quality of repair tissue (21, 22). 
Previous studies have demonstrated that this repair tissue is structurally and biomechanically 
inferior to the articular cartilage and may not be suitable for a long-term load-bearing function 
(23, 24).  
        Due to the limited ability of articular cartilage for self-repair, and the biomechanically weak 
repair tissue, cartilage defects may gradually expand to cover most area of the articular surface 
under long-term compressive loading, leading to osteoarthritis (OA). OA is the most common 
type of arthritis and affects more than 10% of Canadians aged 15 or older and nearly 27 million 
Americans (25). Moreover, ageing and extended life expectancy would make OA the fourth 
leading cause of disability by 2020 (26). OA is also associated with extremely high economic 
burden, involving the expense of treatment, disability rehabilitation, and early retirement (27). 
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        Treatments for articular cartilage defects include microfracture, autologous chondrocyte 
implantation (ACI) and osteochondral autologous transplantation (OAT). In microfracture 
procedure, impaired cartilage is removed and the subchondral bone is penetrated to expose bone 
marrow. The bone mesenchymal stem cells in bone marrow will access and fill the cartilage 
defects. Nevertheless, as mentioned before, the newly formed tissue is fibrocartilage which 
mainly consists of Collagen type I, while the major type collagen in articular is Collagen type II. 
Fibrocartilage shows much lower biomechanical properties to articular cartilage and may lead to 
further degeneration under long-term load (28). In ACI procedure, patient’s chondrocytes are 
isolated from a healthy region and expanded in tissue culture laboratory. Cells are re-implanted 
into the damaged area once enough cells have been obtained. Articular cartilage or fibrocartilage 
are newly formed by ACI technique. Disadvantages of ACI include donor site morbidity, scarce 
cell sources, and second invasive surgeries (one surgery to collect chondrocytes, one surgery to 
put chondrocytes back to defect area) (29). During OAT surgery, healthy cartilage along with 
part of its underlying bone is transferred to fill the damaged cartilage area. This surgery will 
come with donor site morbidity, which are not desirable for patients (30). 
        Surgeries including osteotomy (31) and arthroplasty (32) are usually needed once small 
focal defects develop into OA. Osteotomy relieves pressures of the defect area by reshaping bone 
to change its alignment towards the healthy area and thus relieving pain in early-stage OA. 
However, due to the serious nature of the procedure and in long-term run, it could result in joint 
deterioration, it is being replaced by arthroplasty especially for seniors. Arthroplasty, or joint 
replacement, is used to treat serious OA and mainly involves replacing the suffering joint with 
artificial prosthesis. Nevertheless, it is reported that the treated joints could hurt again several 
years later since the implanted prostheses are worn out (2, 33). Moreover, arthroplasty is not a 
suitable procedure to treat young patients because of their growing skeletons (34). Therefore, 
exploring an effective approach to treat cartilage defects and overcome the drawbacks of above-
mentioned treatments remains a challenge. 
 
1.2 Cartilage Tissue Engineering 
        Tissue engineering (TE) strategies have been employed with the aim to improve the quality 
and longevity of repair tissue and long-term patient outcome (35). In articular cartilage tissue 
engineering (CTE), cells and/or bioactive molecules are delivered to the defect area through a 
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scaffold to fill and regenerate cartilage lesions (36). Choosing suitable cell sources is important 
to CTE, especially for bioprinting of engineered cartilage. As the only cell type in cartilage, 
chondrocyte is a natural choice for CTE. Besides, stem cells have also been explored for 
application in CTE due to their multipotency (37). Hydrogels are attractive as the scaffolding 
material because they can provide desirable conditions for embedded cells. Water-swollen 
polymeric networks of hydrogels mimic native cartilage ECM and provide a favorable 3D 
microenvironment to maintain the morphology and chondrogenic phenotype of embedded 
chondrocytes (38, 39). Also, a homogenous cells distribution with high density can be achieved 
within hydrogels (40-42). Besides, transmitting external stimuli to embedded cells and thus 
directing the growth and formation of a cartilage tissue is another advantage of hydrogel 
scaffolds (43, 44). From the material point of view, native cartilage tissue is a cell-laden 
hydrogel. Different bioactive molecules or growth factors (e.g. bone morphogenetic protein 
(BMP), insulin-like growth factor 1 (IGF), transforming growth factor beta (TGF-β), fibroblast 
growth factors (FGF)) have been investigated independently and synergistically for their 
application in CTE. TGF-β family play an important role in chondrogenesis (45, 46) and 
cartilage development (47). Both IGF-1 and FGF-2 favors cell proliferation and result in more 
and accelerated cartilaginous ECM deposition (48-50). BMPs (mainly BMP2 and BMP7) 
showed positive effects on chondrogenesis and osteogenesis (51, 52), and thus are promising for 
osteochondral defect regeneration studies since they help engineered osteochondral constructs 
anchor into the subchondral bone at the implant site (53, 54). Other than growth factors, 
mechanical stimuli are another kind of stimulating factor for cartilage repair. Various mechanical 
loading regimes from a single loading to continuous loading have been tried to accelerate and 
promote cartilage formation. The time, frequency and value of load are usually needed to be 
optimized according to cell type and scaffold materials (55-57). High-water content of hydrogel 
makes it attractive as bioactive molecules delivery vehicle and embedded chondrocytes can sense 
the external stimuli to stimulate the cartilage tissue formation. 
 
1.3 Bioprinting Cartilage Constructs 
        Bioprinting is an emerging technique that allows for fabrication of complex constructs with 
control over external shape and internal structure. It allows for accurate positioning of biologics 
(e.g. cells, biomaterials, bioactive molecules) in a layer-by-layer manner, thus facilitating the 
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production of customized regenerative cartilage constructs (58). The key to the success of these 
regenerative constructs is to make them biologically active, which is usually accomplished by 
incorporating living cells. It has been shown that the extrusion and laser-based bioprinting 
technologies are promising to incorporate cells with limited harm on the viability or long-term 
performance of the embedded living cells (59-63). Laser-based bioprinting deposits light energy 
on photocrosslinkable prepolymers solutions in predefined patterns and thus can be used to print 
a crosslinked cell-laden hydrogel (64). Extrusion-based bioprinting (EBB) allows for the 
deposition of cell-laden strands through a nozzle and is thought as the most suitable printing 
technique for the bioprinting of viable constructs with high cell densities and several centimeters 
in size (65) Therefore, EBB techniques have been most commonly used in printing cartilage 
constructs with living cells.  
        Hydrogels, as cell carriers, can provide many advantages in tissue engineering to create 
various tissues. A wide range of natural polymers (e.g. alginate, collagen, hyaluronic (HA) acid, 
and gelatin) as well as synthetic polymers (e.g. polyethylene glycol (PEG), Poly (vinyl alcohol) 
(PVA)) have been widely used as hydrogel materials for CTE applications(66, 67). Crosslinking 
can be induced chemically (e.g., with the presence of Ca2+), thermally, or by using ultraviolet 
(UV) or visible light with photo initiators (methacrylate modified HA). To print a biologically 
active cartilage construct, bio-inks are employed as printing materials. In bioprinting, cell-laden 
hydrogels are commonly used and are termed “bio-inks” (65). These bio-inks can facilitate 
homogeneous cell seeding in a highly hydrated and mechanically stable 3D environment. Further 
information about applicable cell types and hydrogel polymers for bio-inks are reviewed in 
Chapter 2 of this thesis.  
        Bio-inks need to be designed in terms of printability so as to facilitate the layer-by-layer 
printing process. High viscosity can provide bio-ink with good printability but limit cell 
migration and matrix deposition. Meanwhile, it is difficult to print low-viscosity bio-inks since 
they tend to be flattened after deposition and have difficulty maintaining the shape as designed. 
Bioprinting of biological active cartilage constructs with living cells for CTE is concerned in this 
thesis.     
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1.4 Mechanical Properties of Bioprinted Hydrogel-based Cartilage Regenerative 
Constructs 
        AC functions to support and transfer loading and allows for rotation between bones. When 
people are doing exercises or sports, AC usually experiences a force several times higher than 
body weight, e.g. AC in knee experiences a force 3.5 times bodyweight  (68). Loading or 
deformation exerts a combination of tensile, compressive, and shear stresses to the articular 
cartilage. As such, more than a single type of mechanical test is typically needed to characterize 
the mechanical properties of native cartilage. Different mechanical testing and their 
corresponding testing results of articular cartilage are listed in Table 1.1. These mechanical 
properties have been discussed and relevant testing protocols for CTE applications have been 
reviewed previously (69). The mechanical properties of bioprinted hydrogel-based cartilage are 
largely inferior to natural cartilage, due to the intrinsic weakness of hydrogels. Various strategies 
have been employed to improve the mechanical properties of 3D printed hydrogels construct; 
these strategies include co-depositing hydrogels and thermoplastic polymers (70), varying 
architectural properties (71), mixing with other polymers (72), incorporating micro/nano fibers 
(73), increasing crosslinking densities (41) and hydrogel precursor concentration (74). This 
thesis also concerns with the influence of internal design on the mechanical properties of 3D 
printed hydrogel scaffolds. 
 
Table 1.1 Compressive, tensile, shear and aggregate moduli of human articular cartilage and bioprinted 
hydrogel-based cartilage constructs. 
Mechanical characterization Human articular cartilage Bioprinted hydrogel-based 
cartilage constructs 
Compressive Young’s modulus 0.45 to 0.85 Megapascal (MPa) 
(41, 72, 75-80) 
0.007-0.250 kilopascal (KPa) 
(30, 60, 67, 68) 
Tensile Young’s modulus 5 to 25 MPa (81-84) 0.116-0.230KPa (72) 
Shear modulus 0.2 to 2MPa (83, 85) Not reported 
Aggregate modulus 0.5 to 0.9 MPa(86) Not reported 
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1.5 The Importance of Calcified Cartilage in Cartilage Regeneration 
        Calcified cartilage is a layer of articular cartilage that serves as a transition from pliable 
cartilage to more rigid subchondral bone (87). As a native osteochondral interface, calcified 
cartilage layer mainly consists of a layer of scarce hypertrophic chondrocytes embedded in the 
mineralized matrix of Collagen types II and X, as well as proteoglycans (88-90). This layer 
serves as a functional junction for cartilage-to-bone and allows for pressurization during loading 
(91). 
        Notably, current cartilage repair strategies mainly focus on employing tissue-engineered 
cartilage constructs to treat cartilage defects (92). However, limited research is on engineering a 
functional and stable osteochondral interface to mimic the functionality of native cartilage, 
which remains a challenge nowadays. It is also noted that the reported approaches to achieve an 
osteochondral interface are mostly cell-based (93, 94) and that deep-zone chondrocytes are 
cultured in a mineralization media and/or on a material substrate containing calcium phosphate. 
The results illustrate that deep-zone chondrocytes can synthesize mineralized matrix (e.g. 
hydroxyapatite, a semicrystalline calcium phosphate) (94). As a general requirement, an 
osteochondral interface should favor chondrocyte viability and facilitate the deposition of 
calcified cartilage matrix (e.g. Collagen type X and mineralized matrix). This thesis also 
addresses the issue on the development of such an interface for the regeneration of calcified 
cartilage.   
 
1.6 Research Objectives 
        By addressing the aforementioned issues, this thesis aimed to bioprint cartilage constructs 
that incorporate living cells and characterize them in vitro for CTE. The specific objectives of 
this thesis were set as follows.    
        The first objective was to fabricate CTE scaffolds based on the bioprinting technique and to 
study the influence of scaffold design on the mechanical performance. Gelatin and alginate 
mixtures were synthesized and printed with the help of thermal/submerged ionic crosslinking 
process, creating porous hydrogel scaffolds. The scaffold geometries, including stand orientation 
and the spacing between them, were adjusted for bioprinting and their influence on the scaffold 
mechanical properties were investigated. 
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       The second objective was to develop a 3D bioprinting technique or process supplemented 
with the submerged cross-linking mechanism to fabricate alginate hydrogel constructs with 
living cells. To this end, cells and alginate mixture were prepared and bioprinted into pre-treated 
well of tissue culture plates containing crosslinking medium. In vitro biological performance of 
the printed alginate constructs was evaluated in terms of cell viability, proliferation and secretion 
of sulfated GAGs and Collagen type II. 
The third objective was to test the hypothesis that homogeneously dispersed 
hydroxyapatite in alginate hydrogel promotes the formation of calcified cartilage matrix. To do 
so, sodium citrate was used to achieve homogenous mixing of hydroxyapatite within alginate. 
Cell growth, extracellular matrix (ECM) production, and mineralization potential were evaluated 
in the presence or absence of hydroxyapatite particles for comparison.   
 
1.7 Organization of the Dissertation 
        The thesis is organized into 6 chapters. It includes the introduction chapter, four chapters 
adapted from four manuscripts, and a chapter summarizing the conclusions drawn from this 
research and the recommendations for future studies. 
        Chapter 2 presents a literature review on the application of extrusion-based hydrogel 
bioprinting for cartilage tissue engineering. It reviews applicable cell sources and toolkits of 
polymer that can be used for bio-ink formulations for CTE, and two bioprinting approaches (i.e., 
self-supporting hydrogel bioprinting and hybrid bioprinting) and their applications in fabricating 
chondral, osteochondral, and zonal organized cartilage regenerative constructs. This is followed 
by the insights on the current limitations and future opportunities of 3D bioprinting of cartilage 
regenerative constructs.  
        Chapter 3 addresses the fabrication of scaffolds based on the bioprinting technique and 
studies the influence of scaffold design on the mechanical performance. With the help of 
thermal/submerged ionic crosslinking process, porous alginate/gelatin hydrogel scaffolds can be 
printed. Then, six scaffold geometries are designed and produced by changing the strands 
orientation and spacing of hydrogel scaffold. The influence of scaffold internal geometry on its 
mechanical performance is investigated.  
        Chapter 4 presents the development of a bioprinting technique for fabricating porous 
chondrocyte-laden hydrogel constructs. The cell viability, cell proliferation, and cartilage ECM 
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deposition of the printed constructs are investigated. The fabrication technique and the printed 
scaffolds obtained support high cell viability and the deposition of cartilage ECM, demonstrating 
their potential for applications in CTE.  
        Chapter 5 presents a study to test the hypothesis that the addition of hydroxyapatite into 
alginate hydrogel promotes the biosynthesis of calcified cartilage matrix. First, homogenous 
mixing of alginate and hydroxyapatite is achieved with the addition of a surfactant. Next, cell 
growth, biosynthesis, and mineralization potential are evaluated with/without hydroxyapatite. 
Last, the printability of the composite hydrogel precursors is examined and verified by printing 
porous scaffolds using a 3D Bioplotter.  
        Chapter 6 summarizes conclusions drawn from this research and recommendations for 
future studies. 
 
1.8 Contributions of the Primary Investigator  
        Manuscripts included in this thesis are co-authored and contributions of all authors are 
highly appreciated; however, it is the mutual understanding of all authors that Fu You, as the first 
author, is the primary investigator of the research work.   
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Chapter 2: Application of Extrusion-based Hydrogel Bioprinting for 
Cartilage Tissue Engineering 
 
This chapter has been published as You, F., Eames, B.F., Chen, X. (2017). Application of 
Extrusion-based Hydrogel Bioprinting for Cartilage Tissue Engineering. International Journal of 
Molecular Science, 18(7), 1597. According to the Copyright Agreement, "the authors retain the 
right to include the journal article, in full or in part, in a thesis or dissertation". 
 
2.1 Abstract 
        Extrusion-based bioprinting (EBB) is a rapidly developing technique that has made 
substantial progress in the fabrication of constructs for cartilage tissue engineering (CTE) over 
the past decade. With this technique, cell-laden hydrogels or bio-inks have been extruded onto 
printing stages, layer-by-layer, to form three-dimensional (3D) constructs with varying sizes, 
shapes, and resolutions. This paper reviews the cell sources and hydrogels that can be used for 
bio-ink formulations in CTE application. Also, this paper discusses the important properties of 
bio-inks to be applied in the EBB technique, including biocompatibility, printability as well as 
mechanical properties. The printability of a bio-ink is associated with the formation of first layer, 
ink rheological properties, and crosslinking mechanisms. Further, this paper discusses two 
bioprinting approaches to build up cartilage constructs, i.e., self-supporting hydrogel bioprinting 
and hybrid bioprinting, along with their applications in fabricating chondral, osteochondral, and 
zonally-organized cartilage regenerative constructs. Last, current limitations and future 
opportunities of EBB in printing cartilage regenerative constructs are reviewed. 
 
Keywords: cartilage tissue engineering; extrusion-based bioprinting; hydrogels; bio-inks; self-
supporting hydrogel bioprinting; hybrid bioprinting 
 
2.2 Bioprinting Is Promising Technique to Process Hydrogel for Fabrication of Cartilage 
Constructs in CTE 
        Bioprinting of personalized complex tissue grafts is promising for overcoming the current 
challenges of cartilage tissue engineering (CTE). Cartilage is a highly hydrated and specialized 
tissue to provide a low-friction, wear-resistant, and load-bearing surface in diarthrodial joints for 
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efficient joint movement (1). Unfortunately, the structure and function of the cartilage are 
frequently disrupted or lost with trauma or aging; and there is no sufficient heal response for 
regeneration as cartilage shows little self-repair tendency. These defects or injuries last for years 
and eventually lead to arthritis (2). To address this problem, tissue engineering (TE) approaches 
aiming to engineer constructs to regenerate cartilage defects are under active investigation. 
Ideally, the tissue-engineered constructs for CTE should fill cartilage defects, resemble 
extracellular matrix (ECM), hold cells in place, and retain a space for the growing tissue (3, 4). 
To this end, hydrogel has been illustrated promising due to the fact that it closely mimics native 
ECM and thus providing a 3D culture microenvironment favorable for encapsulated cells to 
retain the rounded morphology and chondrogenic phenotype (5-7). Furthermore, hydrogels allow 
for achieving high cell seeding density and homogenous cell distribution throughout scaffold (6, 
8-14), and transmitting external stimuli to embedded cells so as to direct growth and formation of 
the regenerating cartilage (15, 16). Several disadvantages of hydrogels, however, have also been 
identified, such as weak mechanical strength and stability. It is also hard to handle and process 
hydrogels into cartilage regenerative constructs with desired internal structure and external 
shape. To overcome these problems, the bioprinting technique has been rapidly developing and 
gaining interest for fabrication of customized cartilage constructs. 
        Although some reviews on bioprinting of tissues and organs are available, investigation into 
the EBB cartilage constructs from bio-inks has not been well-documented. This article presents a 
brief review of the application of EBB for fabricating cartilage constructs from bio-inks, 
covering its working principles, applicable cell sources and materials, printability, printed 
cartilage constructs, as well as future perspectives of bioprinting cartilage. 
 
2.3 EBB for CTE 
2.3.1 EBB 
        Rapid prototyping (RP), also known as solid freeform fabrication, refer to a series of 
techniques that manufacture objects through sequential delivery of energy and/or material in a 
layer-by-layer manner per computer aided design (CAD) data. The external shape and internal 
architecture of the scaffold can be defined by either 3D computer models or clinical imaging data 
(e.g. the defect area of the patient can be scanned by magnetic resonance imaging or computed 
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tomography) (17, 18). Once the external/internal geometric information is determined, the RP 
system is programed to fabricate the scaffold as designed. 
       RP techniques can be divided into three classifications based on their working principles: (i) 
laser-based; (ii) extrusion-based, and; (iii) printer-based systems. Among various RP techniques, 
extrusion-based bioprinting (EBB) stands out for its unique advantages. EBB allows for 
production of 3D tissue constructs from bio-inks by a layer-by-layer deposition process in a 
designed way (19). EBB also allows for higher cell seeding density, higher printing speed to 
facilitate scalability, and relatively less process-induced cell damage (20). EBB can print 
continuous cylindrical filaments from almost all types of bio-inks to high cell density aggregates 
of a wide range of viscosities. Once the bio-ink is printed, it can be crosslinked by ionic, photo, 
and/or thermal crosslinking mechanisms (Figure 2.1). Given the complexity of biological tissue, 
multiple bio-inks are often used to fabricate a tissue construct, which is also achievable by using 
EBB with multiple printing heads. 
 
 
Figure 2.1 Schematic of extrusion-based bioprinting using various crosslinking mechanisms. 
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2.3.2 Bio-inks 
        Hydrogel precursors and living cells are two important components of bio-ink formulations. 
Cell sources and hydrogel types employed for encapsulating chondrogenic cells are reviewed 
below. 
 
2.3.2.1 Applicable Cell Sources 
        The choice of cells is a central problem to any modality of tissue engineering. For cartilage 
bioprinting, several factors need to be taken into consideration when choosing suitable cell 
sources: i) cells must be robust enough to survive any shear stress and pressure during the 
printing process; ii) cells must proliferate well; and iii) cells must possess biosynthesis levels 
(e.g. of proteoglycans, collagen type II) comparable with cartilage cells in vivo so they can 
maintain their biological functions (21). So far, the use of chondrocytes over stem cells for 
cartilage bioprinting is predominant (Table 2.1).  
        Consistent with the distinct zonal structure of native articular cartilage (22), chondrocytes 
from different zones show different characteristics of biosynthesis levels. Superficial zone has a 
dense network of collagen fibers that are parallel to the articular surface, while collagen fibers 
are randomly arranged in the middle region and perpendicular to the subchondral bone in the 
deep zone (23). The content of the other important component in cartilage, proteoglycan, is 
lowest in the superficial zone and increases through the middle and deep zones (24). Limited 
numbers of chondrocytes in articular cartilage make it necessary to expand chondrocytes before 
use. The monolayer expansion process usually leads to chondrocyte dedifferentiation with 
decreased GAG synthesis and Collagen type II expression (25, 26). Most studies typically use 
chondrocyte mixtures from full-thickness cartilage (27-29) to obtain higher cell populations. 
Recently, more attention has been focused on employing zonal chondrocytes to achieve different 
purposes. For example, deep zone chondrocytes are utilized to engineer a functional 
osteochondral interface by coculturing with calcium phosphate (30). Chondrocytes isolated from 
the superficial layer exhibit increased proteoglycan 4 expression, and thus superficial 
chondrocytes are promising to be used as the cell source for engineering articular surface (1). 
Articular chondrocytes provide researchers with a unique opportunity to replicate the native 
zonal structure by embedding and culturing zonal chondrocytes in different layers of gels, 
although it is still elusive if this is a promising approach or an overcomplicated strategy (31). 
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Donor site morbidity during harvesting of joint cartilage further limits the use of articular 
chondrocytes (32). Therefore, nasoseptal chondrocytes, as another autologous chondrocyte 
source, is also explored for bioprinting cartilage constructs (33, 34). Another promising cell type 
is the multipotent mesenchymal stem cell (MSC), which can be derived from multiple tissues, 
such as bone marrow, adipose tissues, synovium, periosteum, and muscle. These stem cells can 
be differentiated to undergo chondrogenesis with the supplement of specific growth factors (35, 
36), such as transforming growth factor beta family (37) and therefore they have been explored 
to be used in CTE (38-44). 
 
Table 2.1 Cell sources that have been used in CTE or cartilage bioprinting. 
Cell 
Source 
Features 
References for 
Application in 
CTE 
References for 
Application in 
Bioprinting for 
CTE 
Chondrocytes  
Articular 
ease of induction, make it easy to replicate native zonal 
cartilage by using zonal chondrocytes. Invasive 
harvesting procedure, donor site morbidity, low cell 
yields, low bioactivity, tend to dedifferentiate during 
expansion. 
(45–51) (48–51) 
Auricular 
elastic cartilage, Faster cell proliferation rates than 
articular chondrocytes, produce more biochemically and 
histologically similar cartilage than articular 
chondrocytes when implanted in vivo. 
(52–54) - 
Nasoseptal 
hyaline cartilage, proliferate faster and less tendency of 
dedifferentiation than articular chondrocytes when 
culturing monolayer, capable of producing a cartilage 
ECM with a high GAG accumulation and collagen II/I.  
(33,34,55,56) (33,34) 
MSC  
Bone 
marrow 
high differentiation potentials and less morbidity during 
harvesting, chondrogenesis under appropriate culture 
conditions, involving the supplementation of growth 
factors such as TGF-β, FGF-2.  
(38,57–59) (58) 
Adipose 
differentiating into chondrocytes in the presence of TGF-
β, ascorbate, and dexamethasone, lower chondrogenesis 
potential than stem cells from other sources, lower 
deposition of cartilage ECM than other cell types. 
(39,60,61) - 
Muscle 
differentiation into various lineages, induction to 
chondrocytes with the addition of BMP-2, improved 
healing of cartilage defect with an efficacy equivalent to 
chondrocytes.  
(40,41,62–64) - 
Synovium 
greater chondrogenic potential than stem cells from other 
sources, comparable biosynthesis level with articular 
chondrocytes in terms of type II collagen, aggrecan. 
(62,65–67) - 
Periosteum 
good accessibility, proliferate faster that stem cells from 
other sources, and capability to differentiate into multiple 
mesenchymal lineages, including bone and cartilage. 
(42,68) - 
 23 
 
2.3.2.2 Applicable Hydrogel-forming Polymers for Formulating Bio-inks 
        Hydrogel cross-linking mechanisms are generally categorized into ‘physical’ crosslinking 
and ‘chemical’ crosslinking. Physical (thermal (69, 70) ionic (71) and photo (72)) crosslinking 
include reversible entangled chains, hydrogen bonding, etc. while chemical (enzyme (73) and pH 
(74)) crosslinking are permanent junctions formed by irreversible, covalent bonds. Hydrogel can 
be classified into two groups based on their sources: natural hydrogels (e.g. agarose, alginate, 
cellulose, gelatin, gellan gum, hyaluronic acid, collagen, fibrin) and synthetic hydrogels (e.g. 
Pluronic® F127, PEG and PVA). Hydrogels that are biocompatible for encapsulating stem cells 
or chondrogenic cells for CTE are summarized and reviewed (Table 2.2). There are pros and 
cons to each type of these hydrogels and researchers attempted to modify these polymers to 
improve their properties like bioactivity, mechanical properties, and printability. 
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Table 2.2 Toolkit of Bio-ink formulation. 
 Crosslinking Advantages 
Disadvanta
ges 
Encapsulated Cells 
Referenc
es in 
Other 
Techniqu
es 
Referenc
es in 
Bioprinti
ng 
Agarose 
thermal 
crosslinking at 
26-30 °C, 
agarose solidifies 
when 
temperature is 
lower than the 
thermal 
crosslinking 
temperature 
simple and 
non-toxic 
crosslinking 
process, good 
mechanical 
properties, 
and stability 
of printed 
construct 
not 
degradable, 
poor cell 
adhesion, 
impaired cell 
viability due 
to high 
temperature 
to dissolve 
agarose 
bone marrow stem 
cells(BMSC), 
adipose stem Cells 
(ASC) 
(75–77) (78) 
Alginate 
ionic 
crosslinking with 
divalent cations 
rapid gelation, 
high 
printability, 
biocompatible
, good 
stability, and 
integrality of 
printed 
construct 
poor cell 
adhesion, 
this 
disadvantage 
can be 
overcome by 
modifying 
alginate with 
RGD, 
collagen 
type I or 
oxygenation 
BMSC, ASC, 
chondrocytes 
(79–81) (82) 
Methylcellul
ose 
thermal 
crosslinking 
below 37 °C, 
silanized 
hydroxypropyl 
methylcellulose 
can be 
synthesized to be 
crosslinked by 
changing pH 
good 
printability, 
biocompatibili
ty 
partially 
degrade 
when 
culturing in 
cell culture 
media and 
therefore not 
suitable for 
long-term 
culturing 
chondrocytes (83–85) (35) 
Chitosan 
ionic or covalent 
crosslinking 
biocompatibili
ty, 
antibacterial 
slow 
gelation rate 
and poor 
mechanical 
properties 
without 
modification 
BMSC (86–88) (89) 
Gellan gum 
thermal 
crosslinking or 
ionic 
crosslinking with 
divalent cation 
biocompatible
, high 
printability 
poor cellular 
adhesion 
ASC, nasal 
chondrocytes 
(90–92) (93,94) 
Hyaluronic 
acid 
ionic or covalent 
crosslinking, 
functionalized 
with 
promote cell 
proliferation, 
fast gelation, 
high 
fast 
degradation, 
poor 
mechanical 
BMSC, 
chondrocytes,fibrobl
asts 
(95–98) (99) 
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methacrylate to 
be 
photocrosslinkab
le 
printability 
with suitable 
modification, 
have 
lubricating 
properties 
properties 
and stability 
without 
modification 
Gelatin 
thermal 
crosslinking, 
photocrosslinkab
le polymers can 
be obtained by 
functionalization 
withmethacrylam
ide side groups 
to make it stable 
at 37 °C 
biocompatibili
ty, high cell 
adhesion 
support cell 
viability and 
proliferation 
poor 
mechanical 
properties 
and stability, 
low 
printability 
BMSC, fibroblasts, 
chondrocytes 
(100–102) 
(69,72,10
3) 
Collagen 
pH crosslinking 
(7-7.4) at 37 °C 
or thermal 
crosslinking 
biocompatibili
ty, high cell 
adhesion, 
promote cell 
proliferation 
and serve as a 
signal 
transducer, 
high 
printability 
low gelation 
rate, poor 
mechanical 
properties 
and stability 
BMSC, fibroblasts, 
chondrocytes 
(104–106) (107,108) 
Fibrin 
enzymatic 
crosslinking, gels 
when combining 
fibrinogen, Ca2+ 
and thrombin at 
room 
temperature 
biocompatibili
ty, high cell 
adhesion, 
rapid gelation 
limited 
printability 
and poor 
mechanical 
properties 
BMSC, 
chondrocytes 
(109) (110–112) 
Matrigel 
irreversible 
thermal 
crosslinking at 
24-37 °C 
biocompatibili
ty, support 
cell viability, 
differentiation
, printability 
slow 
gelation and 
poor 
stability 
BMSC, 
chondrocytes 
(113–114) (115) 
Pluronic® 
F127 
thermal 
crosslinking 
biocompatibili
ty, high 
printability, 
support cell 
viability 
Weak 
stability and 
mechanical 
properties, 
fast 
degradation, 
slow 
gelation 
BMSC, fibroblasts 
(74,116–
117) 
(118) 
Poly(ethylen
e glycol) 
radiation 
crosslinking or 
free radical 
polymerization 
biocompatibili
ty, support 
cell viability, 
easily 
modified with 
various 
functional 
groups 
poor cellular 
adhesion, 
low cell 
proliferation 
rate 
BMSC, 
chondrocytes 
(119–120) (121) 
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2.4 Important Properties of Bio-inks 
2.4.1 Biocompatibility 
        Biocompatibility must be considered before the application of any material for tissue 
engineering and regenerative medicine. Biocompatibility refers to the ability of a biomaterial to 
perform its desired function without eliciting any undesirable biological effects (122). For the 
purposes of this review, a bioprinted hydrogel must be cytocompatible, nonimmunogenic and 
have nontoxic byproducts of degradation without eliciting any detrimental effects from the time 
of bioprinting to in vitro maturation and in vivo implantation (123). The main factor that could 
influence the biocompatibility given the same material lays in the bioprinting process, which 
means the whole printing process needs to be cytocompatible. In most cases, bio-inks are stored 
as liquids in a reservoir prior to being dispensed onto the printing surface and a crosslinking 
process is followed to solidify the bio-inks. The cytompatibility of this process is characterized 
by the cell viability test using live/dead staining (124). To elevate the cell viability, bio-inks are 
designed to minimize the stress-induced damage to cells due to the sensitivity of cells 
encapsulated in the bio-inks. In the cases of printing mechanisms involving the use of heating or 
pressure, the heating temperatures are kept within the range favoring cell survival and the 
pressure is maintained as low as possible. 
 
2.4.2 Printability 
        Printability of a bio-ink, once printed in a layer fashion, is its ability to form and maintain a 
3D construct with structural fidelity and integrity. Printability is considered to be associated with 
surface tension, viscosity, rheological properties, and crosslinking mechanisms. Standardized 
tests to quantify the printability still do not exist, and an optical examination method is usually 
adopted to do a geometry comparison (e.g. pore size, fiber diameter) between generated 
constructs and CAD data (125, 126). 
 
First-layer formation 
        The printing and formation of the first layer of bio-inks play an important role for 
fabricating the whole construct, which can be largely determined by the contact angle between 
the printed strand and the receiving surface. Contact angle, also known as wetting angle, is 
measured at where a liquid meets a solid surface. It quantifies the wettability of a solid surface 
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by a liquid. A relatively large contact angle between dispensed bio-inks and the substrate help to 
maintain the vertical dimension of printed bio-inks and avoid the flattening of the printed 
hydrogel precursor solution. The interaction between printed bio-inks and substrate is crucial, 
since suitable interaction helps to anchor the whole bioprinted construct on the printing surface 
and avoids possible deformation and undesired movement during the layer-by-layer bio-inks 
deposition process. Unfortunately, most receiving surfaces such as glass or plastic have poor 
contact angles with bio-inks owing to the materials properties and it is difficult to establish any 
interaction between receiving surface and dispensed bio-inks. These issues could be addressed 
by either printing hydrogels in a hydrophobic high-density fluid, such as perfluorotributylamine 
(78), or coating a thin layer of chemicals, such as 3-(trimethoxysilyl) propyl methacrylate, on the 
printing surface (127) to enhance their hydrophobicity. Polyethylenimine was used successfully 
in our group to pre-treat the culture plates to establish an electrostatic interaction between printed 
cell-laden hydrogel and the receiving surface (128). 
 
Viscosity 
        Viscosity describes the internal resistance of a fluid to flow upon application of stress. The 
viscosity of a polymer solution is determined by its concentration, molecular weight, and 
temperature. Higher polymer concentration and molecular weight are associated with higher 
viscosity. Typically, sufficient viscosity of bio-inks leads to good printability, since it can help 
the bio-inks to overcome the surface-tension-driven droplet formation and be drawn to form 
continuous strands. Sufficient viscosity will also help the dispensed strands to maintain the 
cylinder shape and keep adjacent strands from merging together, which also explains why 
thermoplastic polymers are usually printed with higher accuracy and resolution than hydrogels. 
However, cells thrive best in an aqueous environment, in which their matrix deposition is not 
limited by the dense crosslinked polymer network (129). Bio-inks with high viscosity require 
high pressure to expel them out of the dispensing needle; in this case, the embedded cells are 
exposed to a high shear force, which may impair cell viability (130).  
        The viscosity of a bio-ink solution is mainly determined by the polymer concentration and 
molecular weight. Given that bio-inks with high concentrations may not be favorable for cell 
proliferation/migration and ECM formation (129), it is reasonable to choose low concentrations 
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of high molecular weight polymers for better printability in bioprinting. This also explains the 
success of natural polymers in the bioprinting area. 
 
Shear Thinning 
        Shear thinning is another desirable feature for bio-inks that will help to improve the 
printability, and it refers to the fact that viscosity decreases as shear rate increases (131). Shear 
thinning behaviour is more obvious in polymer solutions with higher concentrations. When shear 
thinning bio-inks are exposed to high shear rates inside a nozzle during bioprinting, a decreased 
viscosity or shear stress will be present, which favors the survival of embedded cells. 
Meanwhile, a sudden decrease of shear rates upon deposition causes a sharp increase in 
viscosity, resulting in a high printing fidelity. 
 
Crosslinking mechanisms 
        The printability is also influenced by how easily and efficiently materials can be 
crosslinked. EBB usually requires printing a cell-laden polymer solution followed by initiating 
gelation immediately after extrusion. The cell-laden polymer solution must be either prepared 
quite viscous or crosslinked rapidly after dispensing onto the printing surface to achieve good 
printability and shape fidelity. However, high viscosity is not ideal for its application in tissue 
engineering and impedes cells survival and proliferation (132, 133). Therefore, a relatively rapid 
crosslinking process is usually desirable in the printing process. Currently, ionic, photo and 
thermal crosslinking are most commonly-used crosslinking mechanisms in bioprinting (Table 
2.2). 
 
2.4.3 Strategies to Strengthen Mechanical Properties of Engineered Cartilage Construct 
        Engineered cartilage should maintain sufficient mechanical properties after bioprinting to 
provide embedded cells with a stable environment for attachment, proliferation, and 
differentiation. Particularly for cartilage bioprinting in CTE, mechanical properties are crucial 
because the functions of cartilage mainly rely on their mechanical performance. Mechanical 
properties of hydrogel are intrinsically weak compared to cartilage (134). Strategies have been 
developed to strengthen the initial mechanical performance of engineered constructs. 
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        Research has supplemented hydrogel with mineral particles (e.g. hydroxyapatite) to create 
composite hydrogels, by combining organic and inorganic phases to obtain desirable properties 
including the improvement of mechanical properties and enhancement of biological properties 
(135, 136). In CTE, the presence of calcium phosphate has been shown to promote chondrocyte 
hypertrophy and Collagen type X deposition and thus improve the regeneration of calcified 
cartilage (30, 137). Moreover, hydroxyapatite would be a good supplement in scaffolding 
materials in CTE to recruit endogenous cells in vivo to regenerate articular surface without cell 
transplantation (138).  
        A novel approach reinforced hydrogel constructs by incorporating printed polycaprolactone 
(PCL) scaffolds. Hydrogel precursors were poured and perfused into the printed porous PCL 
scaffold and crosslinked. In this way, the stiffness of the resulting constructs could be tailored to 
that of native cartilage by reinforcement with high-porosity PCL scaffolds (139). Fabricating 
cartilage constructs by alternating printing injected-printed hydrogels and electrospun 
thermoplastic polymer fibers is also feasible (108). It would be a promising technique if 
electrospun thermoplastic polymer fibers can be incorporated into EBB to print constructs with 
native mechanical characteristics. 
        A higher mechanical strength can also be achieved by blending multiple polymers and 
varying the molar ratio of bio-ink components. From instance, nanocellulose and alginate 
composite bio-ink was synthesized and printed to fabricate chondrocyte-laden constructs. 
Increasing the alginate fraction in bio-ink formula would lead to an increase in compressive 
modulus of printed constructs (34).  
        Making use of the crosslinking mechanism is also an efficient way to enhance the 
mechanical properties of the printed constructs. For example, a three-step method was used to 
crosslink alginate hydrogel for improved elastic stiffness; and the three steps are the primary 
calcium ionic cross-linking to increase the initial viscosity of alginate, secondary calcium ionic 
crosslinking to solidify the printed structure, and tertiary barium ionic crosslinking to strengthen 
elastic stiffness (140).  
        Another effective way to enhance the mechanical properties is the use of hybrid bioprinting 
to co-deposit hydrogels and thermoplastic polymers alternately. Cell-laden hydrogels are 
supported by printed thermoplastic polymers and in this way, these hybrid constructs possess 
mechanical characteristics that was mainly provided by the printed thermoplastic polymer frame, 
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which is significantly higher than the hydrogel-only constructs (141). Meanwhile, by designing 
and changing the architecture of the thermoplastic polymer framework parameters, including 
molecular weight of polymer, strand size, strand spacing, and strand orientation, the mechanical 
properties of the construct can be tuned (142). A covalent bonding based on methacrylate groups 
between thermoplastic polymer methacrylated poly(hydroxymethylglycolide-co-e-
caprolactone)/PCL (pMHMGCL/PCL) and gelatin methacrylamide (GelMA) hydrogel can also 
be established to improve binding in the interface of two materials and further elevate the 
mechanical performance of the engineered construct (29).  
        If a scaffold is designed to initially promote engineered tissue formation in vitro prior to 
implantation in vivo, then they are not required to exactly match the mechanical properties of 
natural cartilage at the initial stage. Thereby many hydrogel-based cartilage bioprinting research 
still focus on formulating bio-inks to favor the synthesis of cartilaginous ECM instead of their 
initial mechanical strength with the hope that the ECM generated by the cells in vitro provides 
sufficient mechanical properties upon implantation in vivo. 
 
2.5 Cartilage Constructs Bioprinting 
        Current cartilage constructs are mainly printed based on two approaches: i) direct printing 
of cartilage constructs from bio-inks (called the self-supporting hydrogel bioprinting) and ii) 
alternating printing of bio-inks and thermoplastic-polymer network (called the hybrid 
bioprinting). The advantages of self-supporting hydrogel bioprinting rests on their mild and 
physiological crosslinking conditions and its relatively-simple process as compared to hybrid 
bioprinting. However, the self-supporting bioprinting requires a high level of printability of bio-
inks and the printed hydrogel constructs typically have week mechanical properties (128). In 
contrast, the thermoplastic-polymer network printed in hybrid bioprinting can offer a sufficient 
mechanical support to the subsequently dispensed hydrogel strands for being crosslinked. 
Therefore, hybrid bioprinting can print a broader range of bio-inks than self-supporting hydrogel 
bioprinting. Nevertheless, the high temperature for melting thermoplastic polymers in hybrid 
bioprinting may impair cell viability. Also, hybrid bioprinting may introduce extra printing errors 
due to its complex process and heating-related stresses within printed constructs (143).  
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2.5.1 Self-supporting Hydrogel Bioprinting 
        Self-supporting hydrogel bioprinting approaches form cartilage constructs for CTE 
application by printing stem cell- or chondrocyte-laden natural and synthetic hydrogels (144). 
Chondrocytes and stem cells embedded within alginate hydrogels has been demonstrated to be 
viable and metabolically active (145). Rapid crosslinking makes alginate a commonly-used 
component in bio-inks to print cartilage constructs. A highly printable bio-ink consisted of 
alginate and nanocellulose was formulated. The printed constructs supported the culture of 
human nasoseptal chondrocytes and had the potential to be printed into more complex shapes 
(34). Alginate has also been sulfated to bind growth factors such as fibroblast growth factor 
(FGF), transforming growth factor (TGF) without losing its printability (146, 147). A 
chondrocyte-laden construct consisting of sulfated alginate and nanocellulose still provided good 
printability and collagen type II deposition (148, 149). Lack of sufficient cell adhesion sites still 
limits the application of alginate in CTE. By incorporating BioCartilage (cartilage extracellular 
matrix particles) and gellan in alginate, the bioactivity and printability of the bio-ink was 
significantly improved and the resulting patient-specific cartilage grafts showed good mechanical 
property and biological properties (27).  
        Hyaluronic acid (HA), as an essential component of cartilage ECM, can mediate cellular 
signaling, wound repair, and ECM organization due to its structural and biological properties 
(150).  More recently, HA is increasingly explored as a “building block” in various bio-inks 
formulations for cartilage bioprinting in CTE because of its viscoelastic and bioactive properties 
(151). Nevertheless, one major drawback of unmodified HA for cartilage bioprinting is the poor 
stability owing to its water solubility. To address the problem of the poor stability of printed HA, 
the photo-crosslinkable dextran derivate or acrylated Pluronic was added to improve mechanical 
properties and the printability of the material. Moreover, embedded chondrocytes demonstrated 
good compatibility with this bio-inks formulation (152, 153). 
        Although gelatin gel has been shown to support chondrocyte viability and differentiation, its 
low viscosity and de-crosslinking at 37 ℃ make it hard to print (154). Therefore, gelatin is 
usually modified to become photo-crosslinkable by a straightforward reaction with an acrylate or 
methacrylate agent (155, 156). For example, a study (102) explored the functionalization, 
preparation and use of cell-laden gelatin methacryloyl (GelMA)-based hydrogels as modular 
tissue culture platforms. For improved printability of gelatin, HA was also incorporated in 
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GelMA and printed chondrocyte-laden constructs supported the viability of embedded 
chondrocytes and cartilaginous tissue formation (50).  
        Acrylation is also commonly used with synthetic hydrogels to facilitate cartilage 
bioprinting. An example is printing poly (ethylene glycol) dimethacrylate (PEGDMA) together 
with human chondrocytes to repair defects with osteochondral plugs through a layer-by-layer 
manner. The printed construct showed a higher mechanical property of 395.73 kPa than most 
printed natural hydrogels. This study demonstrated that hydrogel bioprinting is a feasible 
approach of producing cartilage constructs with anatomic characteristics to accurate targeted 
locations. The embedded human chondrocyte viability was 89% and showed an elevated 
glycosaminoglycan (GAG) content. Also, printed cartilage constructs firmly attached to the 
surrounding tissue and showed even greater proteoglycan deposition at the interface of implant 
and native cartilage (48).  
        Improving the integrity between the engineered cartilage and subchondral bone remains a 
challenge. In this regard, a self-supporting hydrogel construct was printed onto the printed bone 
paste (consisting of demineralized bone matrix and powdered gelatin), to mimic the cartilage and 
subchondral bone respectively (157). Heterogeneous cell-laden high-viscosity alginate hydrogel 
constructs were printed with distinct parts for human chondrocytes and osteogenic progenitors 
for potential use as osteochondral grafts. Embedded cells stayed in their compartment of the 
printed scaffold for the whole culture period and viability remained high throughout the printing 
and culture process and cartilage and bone ECM formation were observed both in vitro and in 
vivo (158). The reported cartilage constructs fabricated by self-supporting hydrogel bioprinting 
are summarized in Table 2.3.   
        To sum up, self-supporting hydrogel bioprinting of cartilage constructs can be processed 
under cytocompatible conditions and printed constructs are generally shown to support cartilage 
ECM biosynthesis. Current research emphasis is focused on formulating bio-inks to achieve high 
printability and improving the mechanical performance of printed constructs. The relatively 
weak mechanical properties of printed hydrogel-based cartilage constructs limit its application to 
regenerating focal cartilage defects, where most of exerted force are born by its surrounding 
tissue. To overcome these issues, hybrid cartilage bioprinting by alternating printing of bio-inks 
and thermoplastic polymers fibers (hybrid bioprinting) has been brought forwarded. 
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Table 2.3 Overview of Publications on the self-supporting hydrogel bioprinting of (osteo)chondral and 
zonally organized cartilage regenerative constructs. 
Material (s) Cell Type (s) 
Mechanical 
Properties 
Crosslinking 
Mechanism 
(s) 
Outcomes Reference 
Hydrogel Bioprinting of Chondral Constructs 
Alginate 
ATDC5 
chondrogenic 
cell line and 
embryonic 
chick 
chondrocytes 
Unconfined 
compressive 
modulus: 20~70 
kPa (depending 
on the culture 
time and 
crosslinking 
densities) 
Ionic 
~85% cell viability, 
show cartilage ECM 
formation in constructs 
(128) 
Nanocellulose with alginate 
Human 
nasoseptal 
chondrocytes 
Unconfined 
compressive 
modulus: 75~250 
kPa (depending 
on the ratio of 
two materials 
Ionic 73~86% cell viability (34) 
Methacrylated chondroitin sulfate 
(CSMA) with a triblock 
copolymer poly (N-(2-
hydroxypropyl)methacrylamide-
mono/dilactate) 
ATDC5 
chondrogenic 
cell line 
Unconfined 
compressive 
modulus: 7~60 
kPa (depending 
on the degree of 
methacrylation) 
Photo ~95% cell viability (159) 
GelMA with gellan gum 
ATDC5 
chondrogenic 
cell line 
Unconfined 
compressive 
modulus: 18~59 
kPa (depending 
on the 
concentration of 
gellan gum) 
Ionic, photo 
and thermal 
Approximately 50% 
cell viability in plotted 
gels due to the 
supraphysiological 
temperature of 
40~50 °C. 
(94,160) 
GelMA with gellan gum 
Equine 
articular 
chondrocytes 
Unconfined 
compressive 
modulus: 2.7–
186 kPa 
(depending on 
ratio and content 
of two 
components) 
Ionic, photo 
and thermal 
Support cartilage 
matrix production, 
higher gellan gum 
contents improves the 
printability but 
compromise cartilage 
ECM, and high total 
polymer 
concentrations hamper 
the distribution of 
ECM.  
(94,160) 
Fibroin and gelatin 
Human 
mesenchymal 
stem cells, 
Human 
articular 
chondrocytes  
Not reported Enzymatic 
84~90% cell viability 
of both cell types 
during 14 days of 
culture, supported 
cartilage ECM 
deposition and 
remodeling, minimize 
hypertrophic 
differentiation towards 
development and 
promote cartilage 
development. 
(73) 
Hydroxyethyl methacrylate 
derivatized dextran (Dex-HEMA) 
and hyaluronic acid (HA). 
Equine 
articular 
chondrocytes 
Ultimate 
compressive 
stress: 100~160 
kPa (depending 
Photo 
Cell viabilities are 
94% and 75% after 
day 1 and day 3 
(153) 
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on the HA 
content), 
uncontained 
compressive 
modulus: 26 kPa 
for different 
constructs 
Diacrylated Pluronic F127 and 
methacrylated HA 
Bovine 
articular 
chondrocytes  
Unconfined 
compressive 
modulus: 1.5~6.5 
kPa (depending 
on the 
methacrylated 
HA content) 
Photo 
Cell viability is 
between 60% to 85%. 
(152) 
GelMA constructs reinforced 
with methacrylated 
pHMGCL/PCL 
Human 
articular 
chondrocytes  
Unconfined 
compressive 
failure force ~2.7 
N and ~7.7 N 
when covalent 
bonds between 
gelMA and 
methacrylated 
pHMGCL/PCL 
are established 
Photo 
Cartilage ECM 
network consisting of 
GAGs and collagen 
type II are formed after 
6 weeks of in vitro 
culture and Collagen 
type II production was 
more pronounced in 
vivo compared to in 
vitro 
(29) 
Gellan, alginate and cartilage 
extracellular matrix particles 
Bovine 
articular 
chondrocytes  
Tensile modulus 
~ 116–230 kPa 
Ionic and 
thermal 
Cell viability: 80% and 
96%, 60% viable cells 
are observed in the 
centre of some 
samples at day 7. 
Constructs with 
cartilage ECM 
particles increased 
cartilage ECM 
formation, but the 
influence of TGF-β3 
on cartilage ECM is 
more pronounced and 
constructs with TGF-
β3 showed most 
cartilage ECM 
formation. 
(27) 
Methacrylated HA with HA-
pNIPAAM 
Bovine 
articular 
chondrocytes 
Not reported 
Thermal and 
photo 
Cell viability is 
negatively influenced 
by the addition of HA-
pNIPAAM. 
(28) 
Hydrogel Bioprinting of Osteochondral Constructs 
Alginate (cartilage)  
Gelatin with demineralized bone 
matrix (bone) 
Cell-free Not reported Ionic 
Directly printing into 
an osteochondral 
defect of a bovine 
femur and showed 
good geometric 
fidelity. 
(157) 
Alginate (cartilage)  
Alginate with biphasic calcium 
phosphate particles (bone) 
Human 
articular 
chondrocytes 
(cartilage)  
Human 
mesenchymal 
stromal cells 
(bone) 
Unconfined 
compressive 
modulus: 4.5–15 
kPa (depending 
on porosity of 
constructs) 
Ionic 
Cell viability: ~89%  
Cartilage and bone 
ECM formed in 
designed regions of the 
constructs after 
culturing for 3 weeks. 
In vivo tests showed 
similar results after 6 
weeks of culture 
(158) 
GelMA with gellan gum Murine Unconfined Photo and Cell viability: 60–90% (93) 
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(cartilage)  
GelMA, gellan gum and 
polylactic acid microcarriers 
(bone) 
mesenchymal 
stromal cells 
compressive 
modulus: ~25–50 
kPa (depending 
on concentration 
of microcarriers) 
ionic 
Hydrogel Bioprinting of Zonally Organized Cartilage Constructs 
Collagen type II 
Rabbit 
articular 
chondrocytes  
(2 × 107 
cells/mL in 
superficial 
zone, 1 × 107 
cell/mL in 
middle zone 
and 0.5 × 107 
cells/mL in 
deep zone) 
Not reported Thermal 
Cell viability: 93% 
Zonally organized 
cartilage constructs 
could be fabricated by 
bioprinting collagen 
type II hydrogel 
constructs with a 
biomimetic cell 
density gradient. The 
cell density gradient 
distribution resulted in 
a gradient distribution 
of ECM.  
(49) 
 
2.5.2 Hybrid Bioprinting 
        A hybrid construct combining advantages of hydrogel and thermoplastics has been brought 
forward, offering potential for application in CTE (141). Scaffolds made from thermoplastic 
polymers provide stronger structural properties, and hydrogels provide a biologically favorable, 
highly hydrated microstructure like native cartilage ECM for chondrocytes. By alternately 
printing thermoplastic polymer and cell-laden hydrogels, hybrid cartilage constructs are yielded. 
This mechanism makes a broader range of bio-inks types available for use compared to 
bioprinting of hydrogels alone, since requirements for viscosity and gelling speed are less 
stringent (141). Also, engineered cartilage fabricated by hybrid bioprinting technique possess 
adequate mechanical characteristics, since thermoplastic polymer framework mainly provides 
mechanical property of the constructs (141). 
        By applying this state-of-the-art printing technology, human nasoseptal chondrocyte-laden 
alginate hydrogel with a supportive PCL structure was printed (33). The study demonstrated in 
vitro and in vivo applications of hybrid constructs encapsulating chondrocytes and growth 
factors in CTE. Another trial explored the feasibility to use embryonic chick chondrocytes as cell 
sources for hybrid printing and comprehensively studied biological performance of the 
embedded chondrocytes. Cell viability, proliferation, and cartilage ECM biosynthesis were all 
kept at high levels in hybrid constructs, confirming the validity of the hybrid bioprinting for 
effective CTE (161). Given the bioinert nature of alginate, it is not an ideal material for 
encapsulating chondrocytes and maintaining their functionality. Therefore, a study printed hybrid 
tissue analogues by dispensing decellularized extracellular matrix (dECM) instead of alginate in 
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the abovementioned hybrid bioprinting system. The results showed the versatility and flexibility 
of hybrid bioprinting process using various tissue-specific dECM bio-inks, including adipose, 
cartilage and heart tissues, which can provide bioactive cues for embedded cells (143).  
        Hybrid bioprinting also showed good suitability to fabricate osteochondral constructs, 
enabling researchers to use different bio-inks in cartilage portion and bone portion. A 
mechanically stable 3D dual cell-laden construct consisting of osteoblasts and chondrocytes for 
osteochondral tissue engineering using a multi-head extrusion-based printing system was 
successfully printed. Two different alginate solutions with encapsulated osteoblasts or 
chondrocytes were deposited into the previously printed PCL framework (162). A more recent 
study from the same research group successfully bioprinted a multilayered construct with three 
distinct layers by varying the hydrogel materials and incorporated growth factors using a similar 
hybrid printing process and achieved the regeneration of osteochondral defects in the knee joints 
of rabbits (163). Overviews of hybrid bioprinting for fabricating osteo (chondral) constructs 
reviewed in Table 2.4. 
        These studies show the promise of hybrid bioprinting as an advanced fabrication technique 
for CTE. However, mechanical stimuli exerted on hybrid construct would probably be mainly 
withstood by the polymeric scaffolds instead of chondrocyte-laden hydrogel because of stress 
shielding (164). This might be an issue when considering mechanical stimuli can positively 
mediate chondrocytes biosynthetic behavior (165) and cartilage tissue remodeling (166). 
Therefore, further studies need to be carried out to determine the influence of mechanical stimuli 
on the engineered hybrid constructs. 
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Table 2.4 Overview of Publications on the hybrid bioprinting of osteo (chondral) constructs. 
Materials Cell Types 
Mechanical 
Properties 
Crosslinking 
Mechanism 
(s) 
Outcomes Reference 
Hybrid Bioprinting of Chondral Constructs 
Alginate 
reinforced 
with PCL 
framework 
C20A4 human 
chondrocyte cell line 
Unconfined 
compressive 
modulus: 6000 
kPa 
Ionic 
Cell viability varies from 70 to 
80%. Co-deposition of 
thermoplastic polymer and 
hydrogel is firstly introduced for 
bioprinting of reinforced 
constructs. 
(141) 
Alginate 
reinforced 
with PCL 
framework 
Human nasoseptal 
chondrocytes 
Not reported Ionic 
85% cell viability, cartilage ECM 
formation in constructs with the 
addition of TGF-β after culturing 
for 4 weeks. Cartilage ECM 
formation is observed in constructs 
with after 4 weeks in vivo.  
(33) 
Alginate 
reinforced 
with PCL 
framework 
Embryonic  
chick chondrocytes 
Not reported  Ionic  
Cell viability: 77~85%; Cartilage 
ECM (GAG and collagen type II) 
is formed in constructs. 
(161) 
dECM 
reinforced 
with PCL 
framework 
Human adipose-
derived stem cells 
(hASCs) and human 
inferior turbinate-
tissue derived 
mesenchymal stromal 
cells (hTMSCs) 
Not reported Thermal 
Cell viability: >90%. The dECM 
provided cues for cells survival 
and long-term functionality. 
Embedded cell synthesizes 
cartilage ECM and expressed 
chondrogenic genes.  
(143) 
Hybrid Bioprinting of Osteochondral Constructs 
Alginate 
reinforced 
with PCL 
framework 
Human nasoseptal 
chondrocytes 
(cartilage)  
Human osteoblasts 
cell line (MG63) 
Not reported Ionic 
Cell viability: ~93.9% for 
dispensed chondrocytes and 
~95.6% for dispensed osteoblasts 
during 7 days of culture. 
(162) 
Atelocollagen 
supplemented 
with BMP-2 
(cartilage)  
CB(6)-HA 
supplemented 
with TGF-β 
(bone)  
The whole 
structure is 
reinforced 
with PCL 
framework 
Human turbinate-
derived mesenchymal 
stromal cells 
(hTMSCs) 
Not reported 
Thermal and 
enzymic 
Cell viability: 93% for 
atelocollagen (bone) and 86% CB 
(6)-HA (cartilage). In vivo results 
showed neocartilage is formed in 
cartilage region while new bone is 
observed in subchondral bone. The 
constructs are well integrated with 
surrounding native tissue in vivo.  
(163) 
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2.6 Zonal Cartilage Bioprinting 
        Zonal cartilage constructs that reflect the native structural depth-dependent characteristics of 
articular cartilage could have advantages over homogeneous constructs. A zonal cartilage 
construct can be achieved by the following strategies i) using zonal chondrocyte subpopulations 
from different zones of cartilage; ii) using a single cell source combined with the correct 
biochemical and/or biomechanical cues; and iii) using different biomaterials and smart scaffold 
designs. Zonal chondrocyte subpopulations from different zones of cartilage tissue can be 
harvested (1, 167, 168), but donor site morbidity, dedifferentiation during expansion, and limited 
availability are the drawbacks of this strategy. Meanwhile, there is still a debate if zonal 
chondrocytes can maintain their phenotype after being isolated from their original biomechanical 
and biochemical environment (31). Comparing with Strategy I, Strategy ii might be an easier and 
more practical technique based on using only one cell source combined with the suitable 
biochemical and/or biomechanical cues. BMSCs have been induced to differentiate into zonal 
chondrogenic cells by co-culturing with various molecules (169-171). This method shows great 
promise since it would be easier to carry out and potentially could solve the problems associated 
with direct isolating zonal chondrocytes from cartilage. A good example of Strategy iii was 
reported by Wise et al (172). They successfully mimicked the cells and ECM organization found 
in the superficial zone by culturing BMSCs on electrospun and oriented PCL scaffolds. Bio-inks 
can be formulated based on these strategies for the fabrication of complex zonal structures. 
Technically, zonal cartilage bioprinting can be realized either by self-supporting hydrogel 
bioprinting or hybrid bioprinting (Figure 2.2). It has been reported that zonal engineered 
cartilage could be fabricated by bioprinting collagen type II hydrogel constructs with a 
biomimetic cell density gradient (49). Even though, zonal cartilage bioprinting is still a 
challenging task probably because of the complexity of fabrication process, involving multiple 
bio-inks preparation, frequent switching between dispensing heads, complicated real-time 
calibration.  
 
2.7 Current Limitations and Recommendations for Future Research  
        EBB is a convenient and promising technique that can print porous tissue-engineered 
constructs with structural and biological properties from a wide range of bio-inks. It still has 
several limitations, including limited biomaterials for bio-ink formulation, cell death during 
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printing, low resolution as well as insufficient mechanical properties. Bio-inks formulation is 
restricted by limited printable biomaterials, which makes up only a small portion of biomaterials 
applied in tissue engineering. To alleviate this problem, development of new biomaterials for 
bio-ink formulation is needed. When formulating and processing new bio-inks, the properties 
discussed in Section 3 should be considered and/or compromised for a given CTE application. 
Further, for clinic application, bio-inks must also satisfy the requirements and regulations as set 
in standards and norms. Unfortunately, such standards and norms are few nowadays and even 
none are directly related to bioprinted implants for tissue engineering, which raises a great need 
for such standards and norms (173). Cell death during the printing process is usually caused by 
the process-induced forces, such as shear stress, exerted on cells (174, 175). This happens 
especially when the bio-ink is highly viscous, in which cells would experience significantly 
higher shear stress (176). Meanwhile, high viscosity possibly induces clogging of the nozzle tip, 
leading to disturbance of the printing process (177-179). However, relatively high viscosity is 
essential for the bio-inks to be dispensed into undisrupted strands with higher resolution and 
printing accuracy. A recent study printed hydrogels in liquid nitrogen to fabricate scaffolds with 
high resolution and precisely defined dimensions (180). But it impaired the cell viability when 
printing with cell-laden hydrogels. Therefore, a compromise is usually needed to be made among 
these factors. Future studies should also focus on new approaches to improve the printability of 
bio-inks without negatively influencing the cell behavior. Research should also be implemented 
on developing new techniques to process bio-inks prior to printing to improve printability. For 
example, increased mixing of alginate and cross-linker solutions actually improved geometric 
fidelity, mechanical properties and cell viability of printed constructs (181-183).   
 
 
 
 
 
 
 40 
 
 
Figure 2.2 (A) Schematic of self-supporting hydrogel bioprinting for fabrication of zonal cartilage 
constructs. Zonal constructs are printed with chondrocytes from the superficial, middle, and deep zones 
incorporated in distinct hydrogel precursors in defined geometries. Reproduced with permission. 
Copyright 2009, Wiley Online Library (145); (B) Schematic of hybrid bioprinting for fabrication of zonal 
cartilage constructs. Alternating steps of printing polymer and zonal cell-laden hydrogels are performed to 
obtain zonal constructs Reproduced with permission. Copyright 2015, Wiley Online Library (32). 
 
        Other printing parameters, including printing pressure, nozzle geometry and diameter, and 
bio-ink concentration, have also been shown to influence cell viability within bio-inks (72, 130). 
Manipulating and optimizing these process parameters can potentially address these issues and 
challenges to some extent. Recent finding also demonstrated the influence of these printing 
parameters on printing accuracy (184). Therefore, we urge that future studies should indicate 
these parameters when investigating new bio-inks to improve consistency and repeatability. 
        To fabricate functional cartilage construct, suitable cell sources, biological cues, and 
construct organization are still needed to be determined for successful cartilage regeneration. 
Most present studies only focus on evaluating cell viability in different bioprinted hydrogels, 
while functionality of the engineered cartilage is not very well characterized. As such, we also 
urge that, for bioprinted engineered cartilage constructs, research should also emphasize the 
overall chondrogenesis within the constructs, either qualitatively (e.g., Alcian Blue and Safranin 
O histology) or quantitatively (e.g., collagen and glycosaminoglycan content, or aggrecan and 
collagen II gene expression).  Moreover, given that the mechanical performance of cartilage 
engineered from hydrogel is usually inferior to native cartilage, research on mechanical 
properties is also required for future cartilage bioprinting studies. Notably, current mechanical 
characterization of engineered cartilage constructs is mainly performed based on a single 
 41 
 
mechanical test (Table 2.4 and 2.5). But a single acceptable mechanical test result does not 
sufficiently prove the engineered constructs can perform its biomechanical functions as good as 
native cartilage tissue. Therefore, a series of mechanical tests (e.g., compression, tensile, and 
shear tests) are needed to be done to comprehensively characterize the mechanical performance 
of bioprinted cartilage constructs (185). 
        Theoretically, the shape of scaffolds fabricated by bioprinting techniques can match 
personalized defects in vivo. Notably, current in vivo research is usually based on man-made 
regular defects, which can be made fitting with a bioprinted scaffold with exact shape and 
dimension. It could be difficult for the in vitro printed material to match perfectly with the defect 
that needs to be regenerated. Printed construct could deform during in vitro culture and defects 
may expand while waiting for implantation. Although defined defects can be created in clinic, 
this is not desirable since it further increases the area that needs to be regenerated. Therefore, the 
concept of “In situ” bioprinting has been performed to directly print alginate hydrogels into a 
defect on an explanted articular surface from a calf (157). This strategy avoids laboratory-based 
constructs culture and multiple surgical intervention and would represent the future of tissue 
engineering using bioprinting techniques for cartilage regeneration. 
        Issues facing CTE is the inability to translate technologies into the clinic and lack of clinic 
standards of materials for human tissue bioprinting. (186). To move bioprinted living cartilage 
implants into clinic application, bio-inks also must satisfy the requirements and regulations on 
safety, sterility, and reproducibility. To ensure safety of bioprinted living implants for clinical 
application and to help researchers qualify and validate the bioprinting process and bio-ink 
formulations, consistent standards are required. Additive manufacturing standards have been 
published by American Society for Testing and Materials (ASTM) F2792. Meanwhile, standards 
for tissue-engineered constructs have been approved by the ASTM international committee F04, 
the International Organization for Standardization technical committee 150/SCZ, and the British 
Standards Institute. Nevertheless, there are no standards is currently available for bioprinted 
implants applied in tissue engineering field (173). To ensure sterility throughout bioprinting, the 
process has to be incorporated in a Good Manufacturing Practice facility, and all components of 
bioprinter should be sterile and can be operated in a sterile environment. Moreover, the whole 
bioprinting process should involve minimal manual handling and operation. Therefore, skilled 
operators are needed to monitor the printing process. Automated, reliable quality control during 
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the printing process will promote the translation of printers into clinics. Having an integrated 
bioreactor system with bioprinters to allow in vitro culture before implantation is also an 
efficient way to avoid undesirable handling of the printed construct and to improve the sterility 
and reproducibility. However, a proven bioprinter-bioreactor setup is not commercially available 
yet.  
 
2.8 Conclusion 
        EBB is an advanced fabrication technique to produce customized cell-laden hydrogel-based 
constructs for CTE to mimic chondral, osteochondral and zonal organization of articular 
cartilage. Despite the advantages and opportunities provided by hydrogel-based EBB for 
cartilage bioprinting, there are still multiple challenges that need to be addressed. Bio-inks for 
EBB need to be synthesized and optimized in terms of their biocompatibility, formulation, 
processing, printability, and optimal cell sources. Self-supporting hydrogel bioprinting and 
hybrid bioprinting are two common approaches to fabricate cartilage constructs. The former 
technique provides a cell-friendly printing environment but limited mechanical strength, while 
the latter brings elevated mechanical properties but the stress shielding may disable external 
mechanical stimuli. Tackling the challenges revolving around bio-inks and mechanical 
performance of resulting cartilage constructs will foster biologically active and living bioprinted 
implants for future clinical applications.  
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Chapter 3: 3D Printing of Porous Alginate/gelatin Hydrogel Scaffolds and 
Their Mechanical Property Characterization 
 
This chapter has been published as You, F., Wu, X., Chen, X. (2017). 3D printing of porous 
alginate/gelatin hydrogel scaffolds and their mechanical property characterization. International 
Journal of Polymeric Materials and Polymeric Biomaterials, 66(6), 299-306. According to the 
Copyright Agreement, "the authors retain the right to include the journal article, in full or in part, 
in a thesis or dissertation". 
 
3.1 Abstract 
        Hydrogel scaffolds with well-defined internal structure and interconnected porosity are 
important for tissue engineering. 3D Bioplotting technique supplemented with 
thermal/submerged ionic crosslinking process was used to fabricate hydrogel scaffolds. Six 
scaffold geometries were fabricated and their influence on mechanical performance was 
investigated. 0/90-0.8 group with the lowest porosity showed the highest Young's modulus while 
the Shift group showed the lowest Young's modulus. Same trend has also been observed for the 
dynamic modulus of each group. Results demonstrated that the mechanical performance of 
hydrogel scaffolds can be tuned by changing the internal structure parameters including strands 
orientation and spacing between strands. 
 
3.2 Introduction 
        Hydrogels are water-swollen polymeric networks, making them an ideal class of materials 
for applications in tissue engineering and drug delivery (1, 2). Due to their high-water content, 
hydrogels could mimic soft tissue better more than other type of polymeric biomaterials. They 
are also attractive for cell delivery and encapsulation as they are able to overcome the 
shortcomings of the traditional post-processing cell seeding, including poor cell-seeding 
efficiency and non-controllable cell distribution (3, 4, 5). As scaffolding materials, hydrogels 
need interconnecting porous structure to ensure continuous and sufficient supply of nutrients and 
removal of metabolites, which is of vital importance for the cell functions of encapsulated cells. 
Although the insoluble cross-linked network generally exhibits permeability for oxygen, 
nutrients, and other water-soluble biomolecules to some extent, it is not good enough for many 
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tissue engineering applications (6). Currently, various rapid prototyping techniques have been 
reported to process hydrogel precursors into porous hydrogel scaffolds (7, 8) and among them, 
three-dimensional (3D) Bioplotting has shown to be a promising technique. By using the 3D 
Bioplotter, the biomaterial solution is dispensed onto a platform through a layer-by-layer 
manner, forming 3D porous scaffolds.   
        Alginate has been widely used to fabricate hydrogel scaffolds for tissue engineering 
application (9). It is a biocompatible and biodegradable natural polysaccharide and its gelation 
can be induced through multivalent cationic transfer. However, alginate lacks adhesion sites for 
cells, thus limiting cell adhesion and cell functions (10). For improvement, cell-recognition 
peptides (e.g., RGD peptides) (11) and/or other biomaterials can be added or mixed into alginate 
hydrogel to enhance cell adhesion. Gelatin (12) is a naturally-derived biopolymer from collagen, 
which contains motifs such as RGD sequences, thus being able to improve the cellular behavior. 
As a biopolymer, gelatin is also known for its suitability for hydrogel printing due to its easy 
preparation and manipulation (13). Therefore, it is rationale to develop a composite hydrogel 
precursor consisting of alginate and gelatin to fabricate porous hydrogel scaffolds, as reported in 
the present study.  
        To fabricate hydrogel scaffolds by mean of 3D Bioplotting, the liquid hydrogel precursor is 
loaded into the dispensing head, dispensed by pressurized air and cross-linked immediately after 
dispensing. Two methods of crosslinking are typically employed for the bioprinting of alginate 
hydrogel, which are (i) aerosol spraying crosslinking (14) and (ii) submerged crosslinking (15). 
The former is usually followed by a submerged crosslinking process to strengthen the cross-
linked network (16). Utilizing aerosol spraying crosslinking may cause the issue that the printed 
hydrogel precursor sinks and designed porous structure collapsed. On the other hand, 
instantaneous crosslinking can be achieved by submerged crosslinking process and help to 
maintain the shape of the printed hydrogel strand and contribute to a more accurate porous 
structure. Therefore, the 3D biolpotting technique supplemented with a submerged crosslinking 
process will be used to produce porous hydrogel scaffolds with the aim to resolve the above-
mentioned issues.   
        It is known that a common disadvantage of porous hydrogel scaffolds is their relatively 
weak mechanical properties, which may result in a failure to match the targeted tissue. Previous 
studies showed that the mechanical properties can be altered and adjusted by varying the internal 
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structures of scaffolds (17, 18). Notably, these studies focused on synthetic polymer or inorganic 
biomaterials, yet the influence of scaffold structure on the mechanical properties of hydrogel 
scaffolds has not been well known and documented. Therefore, in this study, with the help of the 
submerged/thermal crosslinking supplemented 3D Bioplotting technique, various internal 
structures were designed into the porous hydrogel scaffolds aim to tune and enhance their 
mechanical performance.  
 
3.3 Materials and Methods 
3.3.1 Preparation and Rheology of Hydrogel Precursor  
        Type A gelatin from porcine skin (Sigma Aldrich) and low viscosity sodium alginate 
derived from brown algae (Sigma Aldrich) were dissolved in PBS, respectively. The alginate 
solution was then mixed with the gelatin solution, at concentrations of 6% (w/v) gelatin and 3% 
(w/v) alginate, under constant stirring, which was kept at 37°C for 2 h to remove remaining air 
bubbles. Rheological properties of the hydrogel precursor (n=3) were characterized using a 
rheometer (Brookfield, USA).  Specifically, the shear stress was measured at the shear rates 
varying from 0 to 100 s-1 with the temperature fixed at 37 °C; while the storage modulus (G') and 
loss modulus (G'') were assessed by applying 5% strain within the linear viscoelastic region over 
a frequency range between 1 and 100 rad s-1. The gel temperature of the composite hydrogel 
precursor was tested over a temperature ramp starting from 45 °C then decreased to 15 °C (AR 
G2 rheometer, TA Instruments, USA). The rate of temperature change was 1 °C min-1, the 
oscillation frequency was 1 Hz and the constant shear amplitude was 50 Pa. The gel point 
describes the temperature of a material when it solidifies, which is defined by the intersection of 
the storage modulus G' curve and the loss modulus G'' curve during temperature decrease at an 
oscillatory measurement.  
 
3.3.2 Scaffold Fabrication 
        Petri dishes used as plotting platforms were treated with sterile 0.1% (w/v) 
polyethylenimine (PEI, Alfa Aesar, Mw: 60000) in phosphate buffered saline (PBS) and 
incubated overnight at 37 °C. The PEI-coated surfaces were washed with double distilled water 
prior to use. 3D porous scaffolds were produced by sequential strand deposition using the 
Bioplotter pneumatic dispensing system (EnvisionTec, Germany). The designed structure is 
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specified and programed by the CAD/CAM software and then translated into numerical codes by 
the Bioplotter software for the layer-by-layer scaffold fabrication. A 27-gauge plastic dispense 
tip (EFD Nordson, Switzerland) with an inner tip diameter of 200μm was used in this study. The 
composite hydrogel precursor was plotted into the crosslinking medium containing 100mM 
calcium chloride (Sigma Aldrich), 0.1% (w/v) PEI on the cooling platform (Figure 3.1). Six 
internal structures were designed and fabricated, which are 1) each layer adhered to the 
underlying layer perpendicularly to form a 0°/90° with a strand spacing of 0.8 mm (0/90-0.8); 2) 
each layer adhered to the underlying layer to form a  0°/90° with a strand spacing of 1 mm (0/90-
1); 3) the second layer adhered to the underlying layer 0°/45° and the third layer adhered to the 
first layer 0°/135° with a strand spacing of 1 mm (0/45/135-1); 4) each layer adhered to the 
underlying layer perpendicularly to form a 0°/45° with a strand spacing of 1 mm (0/45-1); 5) 
gradient scaffolds exhibiting distinct strand spacing variation with depth (Grad); 6) scaffolds 
with shifted pattern (Shift, means there is a shift between adjacent printed strands along X or Y 
axis). The illustration of these designed structures is presented in Figure 3.5, along with their 
characterization. 
 
3.3.3 Characterization of Hydrogel Scaffolds  
        Hydrogel scaffold swelling was assessed by measuring the scaffold weight over the first 3 
days upon their immersion in PBS. Two experimental setups were analyzed with the hydrogel 
scaffolds. For the first setup, hydrogel scaffolds were freshly printed and their swelling behavior 
at 21°C were assessed immediately after crosslinking. In the second setup, the samples were 
freshly printed but kept at 37 °C during the experiment. The property of swelling is characterized 
and reported by using a ratio of the hydrogel weight over its initial weight. 
        The FTIR spectra were scanned under a room temperature with the IlluminatIR II inVia 
Reflex (Smiths Detection) equipped with an ATR objective. The scanning range is from 650 to 
4000 cm-1 with a resolution of 4 cm-1. Scaffolds were freeze-dried and grinded into powder 
before examination. The top images and cross-sectional images of hydrogel scaffolds with 
different structures were taken with a microscope (Leica, Switzerland). The compressive moduli 
of scaffolds (with a size of 10×10×5 mm) were tested using a Biodynamic testing machine 
(Bose) at a cross-head speed of 0.01 mm/s. The Young's modulus was calculated from the linear 
region of the stress-strain curve for all samples. Creep recovery measurements were performed at 
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37 °C for 24 h in PBS after a 50% deformation. Then, the stress was removed and the samples 
could recover for 24 h. The values reported are the average of five specimens. The percentage 
recovery was calculated using the equation, i.e., Recovery (%) = scaffold height after 24 h 
recovery/initial scaffold height×100%. Dynamic testing was performed by applying 15% 
sinusoidal deformation at 1.0 Hz (19). The dynamic modulus was determined from a ratio of the 
stress amplitude over the strain amplitude after a steady-state response of more than 20 cycles 
(20).  
 
3.3.4 Statistics  
        For quantitative analysis, Student's t tests were used to assess differences between two 
groups and multiple comparisons were performed via one-way ANOVA test using SPSS. P 
values <0.05 were considered statistically significant. Data are expressed as the mean values 
±standard deviation (SD). 
 
3.4 Results and Discussion 
3.4.1 Hydrogel Crosslinking  
        The fabrication of porous alginate/gelatin hydrogel scaffolds was a combination of physical 
and chemical crosslinking processes (Figure 3.1), where the alginate/gelatin hydrogel in a liquid 
form at 37°C solidified with the temperature decreased due to the temperature-dependent 
hysteresis behavior of gelatin and meanwhile, alginate was cross-linked with the presence of 
calcium ions. The fabrication platform (Figure 3.1D) of the 3D bioplotter (Figure 3.1C) was 
connected to a cooling tube (Figure 3.1E) for the control of platform temperature. By adjusting 
the platform temperature below the gel temperature, cross-linking took place in the hydrogel 
precursor Based on the results showed in Figure 3.2C, the gel temperature of the hydrogel 
precursor was found as 22.3°C, and thus the temperature of the plotting platform was set at 10 °C 
to ensure the adequate thermal gelation of the composite hydrogel.  
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Figure 3.1 (A) Underlying mechanism; (B) Schematics of the hydrogel gelation mechanism based on 
reversible thermal gelation of gelatin and irreversible chemical gelation of alginate. Instantaneous 
gelation of gelatin and alginate due to the low temperature of the cooling substrate as well as the CaCl2 
bath; Details of the 3D Bioplotter hardware (C-E): (C) 3D Bioplotter; (D) cooling substrate; (E) Cooling 
tube. 
 
3.4.2 Hydrogel Characterization 
3.4.2.1 Viscosity 
        The viscosity of hydrogel precursor affects the printing process mainly via its flow through 
the dispense tip, where the major pressure drop is caused. Hydrogel precursor with a high 
viscosity would probably clog the dispensing needle tip, thus disturbing the subsequent printing 
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process. In the other hand, if the viscosity of hydrogel precursors is too low, the printed strands 
tend to spread, thus causing the merge of two adjacent strands of the first layer or collapse of the 
other layers. As such, the viscosity of hydrogel precursor must be properly selected and formed 
prior to its bioprinting. As shown in Figure 3.2, at the shear rate near to of 0 s-1, the viscosity has 
its maximum value about 1765 mPa·s; and as the shear rate increases, the viscosity decreases in 
a non-linear fashion, reaching a value of 768 mPa·s at a shear rate of 100 s-1 (Figure 3.2A). The 
curves of the viscosity and shear stress versus the shear rate (Figure 3.2A) illustrate the hydrogel 
precursor is shear-thinning. The curves of storage modulus (G') and loss modulus (G'') of the 
hydrogel precursor versus the frequency is shown in Figure 3.2B. It is seen that the viscous 
component (loss modulus, G'') is higher than the elastic component (storage modulus, G') over 
the frequency varying from 1 to 100 rad/s at 37°C, which suggests the hydrogel precursor is not 
crosslinked prior to its printing. A representative of the gel-point determination is shown in 
Figure 3.2C, where the temperature at which the sol-to-gel transition occurs (G'=G'') is 
determined by the intersection storage modulus G' and loss modulus G''(13). The gel temperature 
is used as a reference temperature for adjusting the temperature of the fabrication platform.  
 
3.4.2.2 Swelling 
        Swelling ratio at 21°C experienced an increase in hydrogel weight caused by PBS uptake of 
the hydrogel scaffold, with a 1.2 to 1.4-fold increase started from fresh hydrogel scaffold. 
Hydrogels equilibrium was reached after 24 h and the fold increase remained between 1.4-1.5. 
Experimental conditions at 37°C led to a swelling ratio of 1.4 after 3 h, but for longer incubation 
the weight dropped to approximate 79% of the original weight (Figure 3.3). Hydrogels are 
known for their swelling behavior, which is important for 3D bioprinting since it changes the 
printed strand size and resulting construct in culture. From the storage and loss modulus of 
hydrogel precursors (Figure 3.2C), hydrogel precursor showed liquid behavior at 37°C. Due to 
the thermal reversible crosslinking of gelatin component, the liquid state of gelatin at 37°C 
accelerates hydrogel degradation, while not similar changes were observed for samples at 21°C 
where gelatin component was still in a solid state. 
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Figure 3.2 Rheological properties of hydrogel composites. (A) Viscosity and shear stress are plotted over 
a shear rate from 0.0001 to 100 S-1; (B) Storage modulus G' and loss modulus G'' of the composite 
hydrogel precursor over a frequency from 1 to 100 rad/s ;(C) Representative image of determining the gel 
point, which is defined as the intersection of storage modulus G' and loss modulus G'' during cooling from 
45°C to 15°C. 
 
3.4.2.3 FTIR Analysis 
        FTIR spectra of alginate/gelatin composite hydrogel is shown in Figure 3.4. The spectrum 
demonstrates the characteristic absorption bands of the polysaccharide structure of alginate 
including 1319 cm-1 (C–O stretching), 1021 cm-1, (C–O–C stretching). The absorption bands at 
around 1557 cm-1 are the stretching peaks of carboxylate salt groups of alginates. The absorption 
peaks at 1621 and 1557 cm-1 represent the vibration of C=N of gelatin indicating the formation 
of Schiff’s base. Notably, a strong peak of amide II at 1543 cm-1, a characteristic of gelatin, is 
absent in the composite hydrogel spectrum, suggesting the involvement of this group in the 
crosslinking reaction (21).  
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Figure 3.3 Swelling of hydrogel scaffolds over 3 days at two experimental conditions. At each time point, 
statistical difference (p<0.05, n=4) was observed between two groups.  
 
 
Figure 3.4 ATR-FTIR spectra of sodium alginate/gelatin composite hydrogel. 
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3.4.2.4 Scaffolds Morphology and Architecture 
        Hydrogel scaffolds with different internal architecture were successfully fabricated. 
Different internal architecture was designed and fabricated by changing the strand/fiber 
orientation and spacing. The CAD 3D models, 2D sections and the morphology of each scaffold 
group are shown in Figure 3.5. Microscopic images of scaffolds show a well-defined geometry 
compared with the CAD models. Both 0/90-0.8 and 0/90-1 scaffold groups have no strand 
distance offset between consecutive layers and the strand deposition angle of 0°/90° created 
quadrangular pores, the only difference between these two groups is the strand spacing. Grad 
scaffold group has a continuous offset (0.1 mm) between consecutive layers. The Shift scaffold 
group owns a shifted pattern, with a constant strand spacing offset of 0.5 mm every other layer. 
By changing the strand orientation in successive layers, 0/45-1 and 0/45/135-1 scaffold groups 
were generated, forming polygonal pores. 
 
3.4.3 Mechanical Analysis 
        Characterization of the mechanical characteristics of the scaffolds is of vital importance in 
many tissue engineering applications. Mechanical properties of each scaffold group are shown in 
Figure 3.6. It is evident that 0/90-0.8 group, which has the smallest strand spacing of all groups, 
owning the highest Young’s modulus (92.36±15.83 KPa) and dynamic modulus (798.0±25.8 
KPa) among all groups. This is because the 0/90-0.8 scaffold group has the lowest porosity. 
When increasing the strand spacing to 1 mm (0/90-1 scaffold group), both of its Young’s 
modulus (53.8±2.9 KPa) and dynamic modulus (423.0±87.6 KPa) demonstrate a significant 
decrease. Bigger strand spacing lowers the mechanical performance, indicating the expected 
relationship between porosity of the scaffolds and the corresponding mechanical properties. 
When changing the strand with 45° angle steps between two successive layers (0/45-1), its 
Young’s modulus (77.1±44KPa) and dynamic modulus (614.4± 23.0KPa) are significantly 
higher than that of 0/90-1 group which has the same strand spacing. This is probably because this 
angular design of scaffolds affords more contact area between the strands from adjacent layers, 
which offers more mechanical strength. (Figure 3.7B) (22) However, successively changing the 
orientation of plotting strands in adjacent layers (0/45/135-1) will further reduce the effective 
contact area (Figure 3.7C) and thus weakening its mechanical performance. 
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Figure 3.5 CAD 2D sections, 3D models and microscopic pictures for scaffolds designed and produced by 
3D plotting techniques for this study. 
 
        When changing the strand spacing distribution (Grad and Shift group), the mechanical 
moduli of the scaffolds are impaired compared with 0/90-1 scaffold group which rigorously 
repeats the exactly same pattern. This indicated that the relative positioning of the strands from 
each layer also plays a key role in determining the final mechanical performance. Shift scaffold 
group showed the lowest Young's modulus (20.3 ±8.0 KPa) and dynamic modulus (103.3±25.0 
KPa) among all scaffold groups, which is likely attributable to the structure of its shifted pattern. 
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A large proportion of the 15% strain probably is mainly counteracted by the deformation of 
internal pores due to its unique shifted structure. (Figure 3.7D) According to the design, it is 
obvious that the Grad scaffold group has the second lowest porosity among all groups, which 
means its mechanical properties probably rank second only to the 0/90-0.8 group. However, it 
turns out that Grad group does not show an elevated mechanical performance as expected, 
indicating that it is the internal structure rather than porosity or strands contact area that 
determines the mechanical properties for the Grad group. The principle behind this is similar 
with Shift scaffold group. Most of 15% strain is likely to be absorbed by the internal pores due to 
the strands offsets and thus reducing the ability of scaffolds to resist compression. 
        Therefore, scaffolds porosity, contact area between strands and spacing variation are 
believed to be three key factors that influence the mechanical performance of scaffolds. 
Mechanical difference between the 0/90-1 scaffold and 0/90-0.8 scaffold can be explained by 
their different porosities. Effective contact area between strands illustrate why 0/45-1 scaffold 
group exhibited higher modulus in comparison with 0/90-1 and 0/45/135-1 groups. Strands 
spacing variation (Grad and Shift scaffolds) lead to an inferior mechanical performance to 0/90-1 
group.  
        Scaffold resilience upon deformation is also very important for applications in tissue 
engineering. The influence of architecture of a scaffold on its resilience was characterized by a 
recovery experiment and shown in Figure 3.6C. 0/90-0.8 scaffolds recovered approximately 63% 
of their initial height after a deformation of 50%, while the 0/90-1 scaffolds recovered 64%. 
0/45-1, 0/45/135-1, Grad and Shift scaffolds groups recovered 68%, 73%, 80% and 82.5% of 
their initial height, respectively. Interestingly, greater stiffness is associated with the lower 
recovery ability. For instance, the 0/90-0.8 group has a compressive modulus of 92KPa, which is 
the highest of all groups, yet showed the lowest recovery of 71%. Shift scaffold group own the 
lowest Young's modulus while it has the highest recovery ability among all groups. This is 
probably because that given a fixed compression deformation, the groups with higher stiffness 
would experience higher stress, which may result in a less recovery. Recovery is also related to 
the internal structure. When most deformation is absorbed by the internal pores of scaffolds 
(Shift and Grad scaffold group), its ability to recover increases. 
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Figure 3.6 (A) Representative strain-stress curves for each group; (B) Young’s modulus (*: p<0.05 
compared with other groups, #: p<0.05 compared with other groups, +: p<0.05 compared with other 
groups, n=3); (C) recovery rate (*, #: p<0.05, n=3) and (D) dynamic modulus of each scaffold group (*: 
p<0.05 compared with other groups, #: p<0.05 compared with other groups, +: p<0.05 compared with 
other groups, n=3). 
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Figure 3.7 The contact area (in black) of the strands with angular design: (A) 0/90-1; (B) 0/45-1; (C) 
0/45/135-1. (D) The deformation of internal pores is responsible for the initial strain of Shift scaffolds.  
 
        Representative curves for stress vs time and strain vs time of each scaffold group are shown 
in Figure 3.8. For solid materials, the applied force would result in the instantaneous strain 
without lags, in this case, the phase angle is 0°. For ideal liquid, the strain lags behind the stress 
by 90° (23).  Because of the viscoelasticity of the porous hydrogel scaffolds, the stress-strain 
response of all scaffold groups exhibited a phase lag between 0° and 90°.  
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Figure 3.8 Stress vs time and strain vs time for groups of (A) 0/90-0.8, (B) 0/90-1, (C) 0/45/135-1, (D) 
0/45-1, (E) Grad, (F) Shift at the loading frequency of 1.0 Hz. 
 
        Notably, the fact that the compressive modulus of each scaffold group is much lower than 
the dynamic moduli at physiological loading frequency suggests that static moduli are not 
sufficiently representative of the functional response of the viscoelastic materials. This is 
especially relevant in tissue engineering studies aiming to achieve a functional tissue substitute. 
Though many researchers used the unconfined compression modulus of tissue constructs as a 
measure of matrix elaboration (24, 25), the present findings indicate that it is also important to 
report the dynamic unconfined compression modulus as it may be more close to physiological 
conditions and thus more representative for tissue engineering application (26).  
        Most commercially available polymeric materials maintain structural integrity by applying 
cytotoxic chemicals or high cure temperatures and lack sufficient mechanical stability during 
printing process. Moreover, the material needs to be kept in liquid state as well as a relative low 
viscosity while in the dispensing syringe to avoid possible clogging of needle tip, but must be 
solidified immediately after contacting the platform or dispensing into crosslinking medium to 
maintain the desired geometry. Therefore, developing a biomaterial suitable for 3D bioprinting is 
still challenging. The hydrogel composite and fabrication technique reported in this study fulfill 
these requirements. Compared with previous work of our lab (15), the difference is the gelatin 
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component, which was included in the material presented in this study. The addition of gelatin 
induced immediate gelation of the preheated hydrogel precursors when contacting the cooled 
substrate due to the thermoreversibility of gelatin, which is good for maintaining the geometry of 
the dispensed strands. Although the chemical crosslinking of alginate component is slower and 
irreversible compared with physical crosslinking process of gelatin, it makes the scaffold stable 
under culture conditions and facilitates long-term stability. Ahn et al. (16) prepared alginate 
hydrogel scaffolds using an aerosol spraying cross-linking technique, which is achieved by an 
aerosol humidifier spraying a cross-linking agent (CaCl2) mist to cross-link the dispensed 
alginate strands. Dispensed strands are usually not sufficiently cross-linked by this technique, 
resulting in the undesired movement during fabrication and loss of porous structure. In the 
present study, simultaneous crosslinking after dispensing is attained by the supplement of the 
thermoreversible gelatin component and a submerged ionic cross-linking process. 
 
3.5 Conclusions 
        In this study, porous alginate/gelatin hydrogel scaffolds were fabricated by the 3D 
Bioplotting technique supplemented with thermal crosslinking and submerged ionic crosslinking 
processes. Various internal structures were designed into the scaffolds by changing the 
orientation and spacing of plotting strands and their influence on the mechanical properties were 
investigated. Porosity, contact area between strands and spacing variation are believed to be 
three key factors that influence the mechanical performance of scaffolds. Notably, dynamic 
modulus of each scaffold was generally much higher than their Young’s modulus suggesting that 
it is also important to characterize the dynamic compression modulus in future study since it may 
be closer to physiological conditions and thus more representative for tissue engineering 
application. 
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Chapter 4: 3D Printing of Porous Cell-laden Hydrogel Constructs for 
Potential Applications in Cartilage Tissue Engineering 
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4.1 Abstract 
        Hydrogels are particularly attractive as scaffolding materials for cartilage tissue engineering 
because their high-water content closely mimics the native extracellular matrix (ECM). 
Hydrogels can also provide a three-dimensional (3D) microenvironment for homogenously 
suspended cells that retains their rounded morphology and thus facilitates chondrogenesis in 
cartilage tissue engineering. However, fabricating hydrogel scaffolds or cell-laden hydrogel 
constructs with a predesigned external shape and internal structure that does not collapse remains 
challenging due to the low viscosity and high-water content of hydrogel precursors. Here, we 
present a study on the fabrication of (cell-laden) alginate hydrogel constructs using a 3D 
Bioplotting system supplemented with a submerged cross-linking process. Swelling, mechanical 
properties and protein release profiles were examined and tuned by controlling the initial cross-
linking density. Porous cell-laden alginate hydrogel constructs were also fabricated and cell 
viability, cell proliferation, and cartilaginous ECM deposition were investigated. The fabrication 
technique and the hydrogel scaffolds obtained supported high cell viability and the deposition of 
cartilaginous ECM, demonstrating their potential for applications in the field of cartilage tissue 
engineering. 
 
4.2 Introduction 
        Hydrogels are three-dimensional (3D) polymeric networks composed of cross-linked 
hydrophilic polymer chains that can absorb and retain large amounts of water. The high water 
content environment makes hydrogels especially attractive for cell delivery and encapsulation (1-
3) as they bypass the issues that occur with post-processing cell seeding (4, 5), such as 
insufficient cell seeding and non-uniform cell distribution (6-8). The resulting cross-linked 
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polymeric networks closely mimic native ECM and, as such, hydrogels can provide a 3D culture 
microenvironment favorable for encapsulated cells (8-10); for instance, a 3D culture of 
dedifferentiated chondrocytes in hydrogels can restore the expression of cartilaginous markers 
(11). Therefore, encapsulating cells in hydrogels is a promising method for providing sufficient 
cell seeding, homogeneous cell distribution and a suitable 3D microenvironment for 
encapsulated cells. Cell encapsulation in hydrogels has been successfully achieved (12-17) and 
several promising techniques, including bioprinting (18), photolithography (19) and laser-
assisted printing (20) have been developed to fabricate cell-laden hydrogels.   
        For cartilage tissue engineering applications, cell-laden hydrogel constructs should be 
highly porous. Porous structure of scaffolds plays a pivotal role in cell growth and migration. 
Larger pores and pore interconnectivity can allow effective mass transfer of nutrients and waste 
(21, 22) but can also result in insufficient cell embedding and intracellular signaling. Smaller 
pores have the opposite challenges (23); also, cell sheets thicker than 100μm may be unable to 
provide sufficient pathways for nutrient perfusion and waste removal, leading to necrosis in the 
center of engineered tissue (24). The viability of porous cell-laden constructs can be around 40% 
greater than non-porous cell-laden constructs (25). Notably, Griffon et al.(26) found that 
chondrocytes proliferation and metabolic activity improved with a pore size range of 70-120μm, 
while Lien et al. reported that scaffolds with pore sizes between 250 and 500μm optimized 
cartilaginous ECM secretion (27). Designing and fabricating 3D cell-laden hydrogels with an 
internal architecture of appropriate pore size and porosity is therefore critical for hydrogel-based 
tissue engineering applications.  
        However, the production of porous cell-laden hydrogel constructs remains challenging and 
is mainly limited by hydrogel processing techniques. 3D printing, in which the biomaterial is 
printed layer by layer, has been widely utilized to fabricate porous hydrogel scaffolds with a 
predesigned internal porous structure and external shape (28). However, two issues remain with 
respect to the fabrication of porous cell-laden hydrogel constructs. First, producing a 
mechanically stable porous hydrogel scaffold that does not collapse is a significant challenge 
(29-31), usually caused by the low viscosity of the hydrogel precursor. Although the viscosity of 
the hydrogel can be increased by increasing the polymer concentration and cross-linking density 
(32, 33), these changes have not achieved shape fidelity while printing and are not desirable for 
cell viability (34). Cells tend to thrive best in a relatively aqueous environment, in which their 
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migration and ECM deposition is not limited by a dense polymer network. Our technique enables 
the fabrication of porous cell-laden hydrogel constructs from a hydrogel precursor with relatively 
low polymer concentrations, which could be more favorable for encapsulated cells (35). Second, 
dispensing or printing conditions (e.g., pressure, temperature, nozzle type) may lead to the loss 
of cell viability (36).  
        Previous researchers fabricated hydrogel constructs using an aerosol spraying cross-linking 
process (37). An aerosol humidifier was used to spray a cross-linking agent (CaCl2) to achieve 
the surface gelation of dispensed alginate strands. However, this method cannot sufficiently 
cross-link the dispensed hydrogel strands, which may lead to movement between layers and 
structural collapse during the dispensing process.  Loss of pores between strands is the result of 
insufficient cross-linking. Moreover, the aerosol spray cross-linking was followed by a second 
process: immersing the scaffolds in the cross-linking solution to further solidify the scaffold 
structure. In the present study, a one-step submerged cross-linking process is employed to 
maintain the porous structure of the printed scaffolds and subsequently fabricate cell-laden 
hydrogel constructs with tunable properties (including swelling, mechanical properties, and 
protein release profile, etc.) for applications in cartilage tissue engineering. The scaffolds are 
fabricated based on a Bioplotting system (38) supplemented with a submerged cross-linking 
technique to allow simultaneous cell encapsulation and pore generation inside the hydrogels 
(39). The current method employed to fabricate cell-laden alginate hydrogel constructs, which 
has several advantages as follows: 1) one-step submerged crosslinking process is effective and 
time saving; 2) this method favors the formation and preservation of printed porous structure, 
especially good for the preservation of the pores between strands because of the buoyancy 
provided by the crosslinking solution. 
        Sodium alginate (SA) was selected as a base hydrogel material. This natural polysaccharide 
can be ionically cross-linked to become a hydrogel in the presence of calcium ions and can 
support chondrogenic differentiation to regenerate cartilage (1, 40). Using a 3D Bioplotter, SA 
solution or cell-impregnated SA was dispensed and fabricated into porous scaffolds on pretreated 
culture plates containing a tailor-made cross-linking medium (Figure 4.1). In vitro results show 
that the porous cell-laden hydrogel constructs obtained support the survival, proliferation, and 
ECM deposition of chondrogenic cells. Therefore, this fabrication technique and the hydrogel 
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scaffolds obtained have great potential for applications within the field of cartilage tissue 
engineering.  
 
Figure 4.1 Schematic of the printing process using a 3D Bioplotting technique supplemented with a 
submerged cross-linking process.  
 
4.3 Materials and Methods 
4.3.1 Polyethylenimine (PEI) Coating and Contact Angle Measurements 
        Linear PEI with a low molecular weight has shown great potential for use in the field of 
tissue engineering and regenerative medicine (41, 42). Tissue culture plates used as plotting 
platforms were treated with sterile 0.1 w/v % PEI (Alfa Aesar, MW: 60000) in phosphate 
buffered saline (PBS) and incubated overnight at 37 °C. Contact angles were tested to investigate 
the influence of the PEI coating process on the plotting surface. Single droplets of 2wt % SA 
(A2033, medium viscosity, Sigma Aldrich) solution were printed on PEI-coated surfaces.  
        Four different situations were evaluated: 
(1) water droplets printed on a non-coated surface, (2) water droplets printed on a PEI-coated 
surface, (3) alginate droplets printed on a non-coated surface, and (4) alginate droplets printed on 
a PEI-coated surface. The static water and SA solution contact angles of single droplets were 
measured at room temperature. Contact angles from the images obtained by a PGX goniometer 
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were measured using Image J image processing software (Open Source) containing the contact 
angle plug in. 
 
4.3.2 Preparation of SA Hydrogel Scaffolds 
        3D porous scaffolds were produced by sequential strand deposition using a Bioplotter 
pneumatic dispensing system (EnvisionTec, Germany). Briefly, the Bioplotter is a three-axis 
dispensing machine that pneumatically deposits (cell-laden) hydrogel precursors on a stationary 
platform. The structural design is programmed in CAD/CAM software, translated into a 
numerical code by the Bioplotter software, and contains information for the layer-by-layer build-
up of the scaffold.  
        To validate the influence of PEI on the printing process, different conditions were applied: 
1) dispensing hydrogel precursors into PEI-free cross-linking medium on a non-coated plotting 
surface; 2) dispensing hydrogel precursors into cross-linking medium containing PEI on a non-
coated plotting surface; 3) dispensing hydrogel precursors into PEI-free cross-linking medium on 
a PEI-coated plotting surface; and 4) dispensing hydrogel precursors into a cross-linking medium 
containing PEI on a PEI-coated plotting surface. The PEI-coated surfaces were washed with 
double distilled water (DDW) prior to use. SA was dissolved in DDW at a final concentration of 
2wt%. The SA strands were plotted into a cross-linking medium containing calcium chloride 
(Sigma Aldrich; 50, 100, or 200mM CaCl2) and 0.1 % w/v PEI using a plotting speed of 7.5, 6.5, 
or 5.5 mm/s, respectively, under a pressure of 0.1 bar through a 200μm conical needle. Each 
layer adhered to the underlying layer perpendicularly to form a 0°/90° strut structure. In this way, 
scaffolds of 10 (length) ×10 (width) ×5 (height) mm with 1 mm strand spacing were created.  
 
4.3.3 Compressive Mechanical Testing  
        The Young’s modulus of each scaffold was determined by applying unconfined 
compression with a universal testing machine (Texture Technologies, MA, USA) at a rate of 
0.01 mm/s. The Young’s modulus was calculated from the slope of the stress-strain curve at a 
target strain of 10%, which is within the physiological range for articular cartilage (43). 
Compressive testing was conducted on three samples from each group to facilitate statistical 
analysis. 
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4.3.4 Swelling Behavior and In Vitro Mass Loss 
        The hydrogel scaffolds obtained were lyophilized and dry weights (W0) were measured. 
Dried hydrogel samples were immersed in 2 mL of DDW and incubated at 37°C. The medium 
was replaced every other day. At scheduled time points (week 0, 1, 2, 3, 4), the specimens were 
retrieved and blotted on a Kimwipe® tissue and then weighed (Wt). The swelling ratio was 
defined as (Wt-W0)/W0×100%. The specimens were then lyophilized and weighed to obtain their 
dry weights (Wd). Mass loss was calculated using the formula (W0-Wd)/W0×100%.  
 
4.3.5 Morphological Examination 
        The printed strands and the top and cross-section view of fabricated scaffolds were 
examined using light microscopy (Leica). The morphologies of the freeze-dried hydrogel 
scaffolds were examined using a scanning electron microscope (SEM; Phenom G2). The samples 
were lyophilized in a freeze-dryer for 24 h and coated with gold using a sputter coater prior to 
examination. 
 
4.3.6 3D Imaging of Porous Hydrogel Scaffolds Structure Via Synchrotron Radiation Based X-
ray 
        The porous hydrogel scaffolds were imaged at the BioMedical Imaging & Therapy facility 
(BMIT) at the Canadian Light Source (CLS) by means of synchrotron radiation based X-ray 
inline phase contrast imaging-computed tomography (SR-inline-PCI-CT). Porous hydrogel 
scaffolds were placed in a sample holder and positioned on the rotating scanning stage for 
imaging. The projected images were recorded at a photon energy of 30 keV by means of a beam 
monitor AA-60 (Hamamatsu) coupled to a camera (Hamamatsu ORCA Flash 4.0) with an 
effective pixel sizes of 12.8 µm. 3D reconstruction was done by Avizo software (FEI, USA). 
 
4.3.7 Protein Release 
        To characterize the release of a model protein from the SA hydrogel scaffolds, 2 mg/mL 
bovine serum albumin (BSA) was dissolved in the SA solutions prior to fabrication. Scaffolds 
were then produced as per the methods mentioned above. After fabrication, the protein-loaded 
scaffolds were further cross-linked in 3mL cross-linking medium containing PEI for another 20 
min. Five µL of the crosslinking medium was taken and treated with 250 µL of Bradford reagent 
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(Sigma Aldrich, Canada) and measured at 595 nm in a microplate reader subtracting blank 
control values. BSA concentration in the above-mentioned cross-linking solutions was used to 
ascertain the encapsulation efficiency and further in vitro release was then performed in fresh 
PBS. The release profile of BSA was evaluated by incubating the SA hydrogel scaffolds in 3 mL 
PBS at 37°C. At each time point (0.5, 1, 2, 3, 4, 6, 12, 24, 48, 72 and 120 h), five µL of release 
medium from each sample were treated with 250µL of Bradford reagent and measured at 595 nm 
in a microplate reader subtracting blank control values. After analysis for each time point, 3 mL 
of fresh PBS was added to replace the medium. The BSA concentration in the unknown samples 
was measured using a calibration curve created from standard BSA solutions (44).  
 
4.3.8 Fabrication of Culturing of Cell-laden Constructs 
        The ATDC5 cell line is derived from mouse teratocarcinoma cells and characterized as a 
chondrogenic cell line that undergoes a process analogous to chondrocyte differentiation. 
Therefore, it is considered a promising in vitro model to investigate the factors that influence cell 
behaviors during chondrogenesis (45). ATDC5 cells were grown in polystyrene dishes and 
cultured in maintenance medium consisting of a 1:1 mixture of Dulbecco's modified Eagle's 
medium (DMEM) and Ham's F-12 medium (Invitrogen) supplemented with 5% fetal bovine 
serum (FBS), 1% penicillin/streptomycin, 1% glutamine, and 1% ascorbate 2-phosphate. The 
cells were harvested at confluence by trypsinization and collected by centrifugation at 1200 g for 
5 min, followed by counting the cell number using a haemocytometer. The cell suspensions were 
homogenously mixed with SA solution using three-way  stopcocks to reach the final cell density 
of 5×106 cells/ml and final SA concentration of 2 w/v%. The mixture was transferred into a 
syringe and loaded into the Bioplotter and then printed to fabricate cell-laden hydrogel constructs 
by means of the procedures described above. The scaffolds were then each washed with DMEM 
for 5 min, followed by culturing in differentiation medium (maintenance medium supplemented 
with 1× ITS premix (insulin, 10 μg/mL; transferrin, 5.5 μg/mL; and selenium, 5 ng/mL) for 1, 
14, or 28 days to induce chondrocyte differentiation (Figure 4.1). The maintenance or 
differentiation media were changed every other day for the duration of the experiment.  
        Primary chondrocytes were also used as a cell source to fabricate cell-laden hydrogel 
constructs. Primary chick chondrocytes were isolated from cartilaginous sternums of 14-day-old 
chick embryos (46). Briefly, the sternums of chick embryos were carefully excised, chopped and 
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placed in digestion medium consisting of 0.2% collagenase and 0.25% trypsin in Hank's 
Balanced Salt Solution (HBSS) at 37°C and 5% CO2 for 2 h with one gentle pipetting at 90 min. 
The digestion was terminated by adding DMEM supplemented with 10% FBS. The resulting cell 
suspension was filtered through a 70 µm sterile Nitex filter and centrifuged at 200 g for 10 min. 
The cell pellets collected were suspended and cultured in culture medium containing DMEM, 
10% FBS, 2mM glutamine, 0.1 mg/mL kanamycin, 1% AA (100U/mL penicillin, 0.1mg/mL 
streptomycin, 0.25µg/mL amphotericin B), and 0.01mg/mL ascorbate. Primary chick 
chondrocytes-laden hydrogel constructs were fabricated following the procedures described 
above. 
 
4.3.9 Cell Viability Using Live/Dead Assay 
        Cell viability studies were conducted using a calcein AM and ethidium bromide (EthD-1) 
solution. (live/dead viability kit, Invitrogen) according to the manufacturer’s instructions. The 
cell-laden hydrogel scaffolds were incubated for 30 min at 37 °C in the live/dead solution. To 
visualize the live and dead encapsulated cells in the SA hydrogel scaffolds, images were 
obtained with a fluorescent microscope (Olympus). To quantitatively determine the cell viability 
in the cell-laden constructs, the stained cells were released by incubating the constructs in 300μL 
50mM EDTA (diluted in DMEM) at 37 °C. By gentle pipetting, the medium was dispersed to 
obtain an even cell suspension mixture. Samples (n=3) were taken from the cell mixture of each 
construct and imaged under a coverslip on a standard glass microscope slide at random locations 
for counting live and dead cells. Cell viability was calculated using the following equation, 
number of live cells/ (number of live cells + number of dead cells) ×100%. A haemocytometer 
was used to count the cell number in these cell suspensions (n=3) over the culture period. 
 
4.3.10 Histological Analysis and Immunohistochemistry 
        ATDC5 cell-laden hydrogel constructs were fixed with 4% paraformaldehyde in Tris-
buffered saline (TBS) for 20 min. The scaffolds were then embedded in OCT embedding 
compound at -80°C for 30 min. Frozen sections (10-μm thick) were prepared with a freezing 
microtome (Leica, Germany).  
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Alcian blue staining  
        To visualize the accumulation of sulfated glycosaminoglycan (GAG), frozen sections were 
stained with 0.25% Alcian blue in 0.1 M HCl for 30 min at room temperature. The accumulation 
of GAG was assessed using light microscopy.  
 
Immunocytochemistry  
        Frozen sections were permeabilized with 0.5% Triton X-100 in PBS (PBS-T), followed by 
pretreatment to block nonspecific reactions with blocking buffer (4% goat serum and 2% sheep 
serum in PBS-T). For collagen staining, the primary immunoreaction was carried out with a 
mouse monoclonal antibody (1:100) against Collagen type II (DSHB), followed by rinsing with 
blocking buffer. The secondary immunoreaction was carried out with Alexa 488-conjugated goat 
anti-mouse IgG (1:1000, Invitrogen) in blocking buffer, followed by rinsing with PBS-T. 
Fluorescent images were recorded with a fluorescence microscope (Nikon).  
        An MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay was 
conducted to characterize the primary chondrocytes-laden hydrogel constructs. Briefly, MTT 
solution (5 mg/mL) was added to each well and the plate incubated again for 5 h. The medium 
was then aspirated and dimethyl sulfoxide added to solubilize the formazan reaction product at 
37 °C for 15 min. The absorbance of each well was measured at 540 nm with a reference at 650 
nm using a micro-plate reader. Alcian blue staining was used to detect sulfated GAG 
accumulation. Briefly, the printed constructs were washed with DMEM and fixed in acetone and 
methanol solution (1:1) on ice for 15 min and then stained with 0.01 % Alcian blue in 3% acetic 
acid solution overnight. The stained constructs were washed with 25% ethanol in 3% acetic acid 
and with 50% ethanol in 3% acetic acid successively, and imaged using light microscopy. 
Immunofluorescent staining was performed on the printed samples to detect the deposition of 
Collagen type II according to methods described above.  
 
4.3.11 Statistics 
        For quantitative analysis, Student's t tests were used to assess differences between two 
groups and multiple comparisons were performed via one-way ANOVA using SPSS software. 
Data are expressed as mean values ± standard deviation (SD), with p values <0.05 considered 
statistically significant. 
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4.4 Results 
4.4.1 Influence of PEI Coating on the Contact Angles of the Plotting Surface 
        To dispense strands and hydrogel scaffolds with high stability and good reproducibility, the 
resolution and precision of the entire process must be considered. To this end, the contact angles 
of droplets printed on both coated and non-coated surfaces were measured. Different contact 
angles were obtained for water or SA droplets printed on PEI-coated or non-coated surfaces 
(Figure 4.2). Contact angles for water droplets printed on non-coated and PEI-coated platforms 
were 34.4±2.1º and 35.3 ±1.7º while for SA droplets were 88.2±1.5º and 68.5 ±4.4º. Notably, the 
contact angles for SA droplets on the non-coated surface are significant higher than SA droplets 
on the PEI-coated surface, which means the wettability between the SA solution and platform 
increased with the PEI coating process.   
 
 
Figure 4.2 (a) Water droplets printed on a non-coated surface, (b) water droplets printed on a PEI-coated 
surface, (c) SA droplets printed on a non-coated surface, (d) SA droplets printed on a PEI-coated surface, 
and (e) contact angle measurements for the four different situations. Error bars represent mean ± SD for 
n=10. *represents significant difference (*p<0.05) between the contact angles of (c) and (d).  
 
4.4.2 Scaffold Fabrication 
        SA strands dispensed in the presence and absence of polycationic PEI were compared 
(Figure 4.3). The first layer of strands cannot form without a PEI coating process (Figure 4.3a, 
b). However, the first layer can be printed when dispensing the SA hydrogel precursor onto a 
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PEI-coated plotting surface (Figure 4.3c), likely because an electrostatic interaction between the 
dispensed strands and the PEI-coated plotting surface was established. However, the upper layers 
did not arrange as designed (Figure 4.3d). Only when the SA hydrogel precursor solution is 
dispensed into cross-linking medium containing PEI on the PEI-coated plotting surface (Figure 
4.3e) can the desired structure be obtained. Porous hydrogel scaffolds were then successfully 
fabricated by a layer-by-layer strand deposition process (Figure 4.3f). Overall, PEI was required 
both as a coating on culture plates and in the crosslinking medium for successful fabrication of 
porous scaffolds. 
 
 
Figure 4.3 (a) Dispensing SA strands into PEI-free cross-linking medium on a non-coated plotting 
surface, (b) dispensing SA strands into cross-linking medium containing PEI on a non-coated surface, (c) 
first layer of dispensing SA strands into PEI-free cross-linking medium on a PEI-coated plotting surface, 
(d) upper layers of dispensing SA strands into PEI-free cross-linking medium on a PEI-coated plotting 
surface, (e) dispensing SA strands into cross-linking medium with PEI on a PEI-coated plotting surface, 
and (f) a fabricated porous hydrogel scaffold. 
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        During the fabrication process, strand size is an important design factor that influences the 
final fabricated 3D structure. Therefore, the dispensed SA strand size for various plotting speeds 
was measured (Figure 4.4). For a conical needle size of 200μm and a dispensing pressure of 0.1 
bar, the SA strand diameter decreased significantly with increasing plotting speed and Ca2+ 
concentration in the cross-linking medium (Figure 4.4b). For the 100mM group, a dispensing 
speed of 6.5 mm/s was chosen because the diameter of the dispensed strand was close to the 
200μm needle size. A dispensing speed of 5.5 mm/s was chosen for the 200mM CaCl2 group for 
the same reason. For the 50mM CaCl2 group, a dispensing speed of 7.5 mm/s was chosen 
because: 1) low deposition speed (lower than 7.5 mm/s) resulted in a too wide strand diameter 
because of the weak cross-linking efficacy caused by the low calcium concentration; and 2) 
higher dispensing speed (high than 7.5 mm/s) would result in the interruptive and unstable 
deposition process.  
        By adjusting the Ca2+ concentration (50, 100, or 200mM) in the crosslinking medium, three 
groups of hydrogel scaffolds were obtained (SA-50mM, SA-100mM, SA-200mM) and their 
morphology observed using SEM. With increasing Ca2+ concentration, the dimensions of the 
freeze-dried strands decreased (Figure 4.5), which is consistent with previous reports of high 
cross-linking density resulting in a denser cross-linked structure (47).  
        Because of the high-water content and low density of the hydrogel, characterizing and 
visualizing the scaffolds by conventional techniques is challenging. Synchrotron-based phase 
contrast imaging techniques were used to characterize the porous hydrogel scaffolds. The 3D 
reconstruction images obtained show the scaffold morphology features a porous structure and a 
highly interconnected pore network (Figure 4.6a,b). Microscopic images show the porous 
structure from top (Figure 4.6c) and cross-section view (Figure 4.6d). The top-view images 
(Figure 4.6b,c) show the pores in the scaffold are completely interconnected with channels 
extending uninterrupted from the top and bottom. The cross-sectional view (Figure 4.6d) shows 
small pores between strands indicating that the pore structure of the scaffold was well 
maintained.  
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Figure 4.4 (a) Representative images of dispensing SA strands into cross-linking medium containing 50, 
100, and 200mM CaCl2 at various plotting speeds (4.5, 5.5, 6.5, 7.5 mm/s) with a needle (200μm) under a 
dispensing pressure of 0.1 bar; (b) SA strand size at various plotting speeds (n=10). The dashed blue 
frame in (b) indicates the plotting speed adopted to fabricate scaffolds for each group. Scale bar=200μm. 
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Figure 4.5 SEM images of SA-50mM (a, d), SA-100mM (b, e), and SA-200mM (c, f) scaffolds and the 
size of freeze-dried strands (g). (n=10, *p<0.05) 
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Figure 4.6 SR-inline-PCI-CT-based 3D reconstruction of porous hydrogel scaffolds (SA-100mM): cross-
section (a) and top view (b); microscopic images of porous hydrogel scaffolds (SA-100mM): top view (c) 
and cross-section (d). Black frame in (d) indicates the pores between deposited layers.  
 
4.4.3 Swelling Behavior and In Vitro Mass Loss  
        All three groups attained their maximum swelling ratio at week 1 (Figure 4.7a). The SA-
50mM and SA-100mM groups then experienced varying downward trends. The swelling ratio of 
the SA-200mM group remained stable for the first three weeks, then decreased at week 4. The in 
vitro mass loss of the SA hydrogel scaffolds is shown in Figure 4.7b. The mass loss for each 
group increased with time, to 46.5, 44, and 33% after 4 weeks for SA-50mM, SA-100mM, and 
SA-200mM, respectively.  
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Figure 4.7 Swelling ratio (a) and percent weight loss (b) of porous hydrogel scaffolds at 37 °C. (* p<0.05, 
between groups. # p<0.05, over time, n=3) 
 
4.4.4 Compressive Mechanical Properties 
The compressive moduli of the three groups of hydrogel scaffolds generally decreased with time 
due to their time-dependent swelling and in vitro mass loss. At each time point, the compressive 
modulus increased with cross-linking density (Figure 4.8).   
 
Figure 4.8 Compressive modulus of hydrogel scaffolds incubated in deionized water at 37 °C for various 
lengths of time (1, 2, 3, 4 weeks). (* p<0.05, between groups. # p<0.05, over time, n=3) 
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4.4.5 Protein Release Experiments 
        Due to the mild biofabrication conditions (room temperature), growth factors can be 
directly loaded into the precursor solutions and plotted to create scaffolds. BSA was used as a 
model protein to investigate the protein delivery ability of the plotted hydrogel scaffolds. The 
encapsulation efficiency for BSA was highest in the SA-200mM group, which was significantly 
higher than the SA-50mM group (Figure 4.9a). Around 80% of the BSA was released within the 
first 48 h in the SA-50mM and SA-100mM groups and 65% in the SA-200mM group (Figure 
4.9b). Specifically, BSA demonstrated a slower protein release behavior with increasing the 
cross-linking density (Ca2+ concentration).  
 
 
Figure 4.9 BSA encapsulation efficiency (a) and release behavior (b) from scaffolds in PBS solution (* 
p<0.05, pH 7.4, 37 °Ϲ, n=3).   
 
4.4.6 Live/Dead Assay 
        Cell viability is an important parameter for cell-laden hydrogel constructs because it 
influences all cellular activities, including proliferation and differentiation. Cell viability was 
assessed with both a live/dead assay kit (Figure 4.10a-i) and as the change in cell number (Figure 
4.10j) with time. Fluorescent images show a dominant population of live cells. Fluorescence 
images of the 3D bioplotted cell-laden hydrogel constructs show a homogeneous cell distribution 
that indicates successful mixing of cells in the SA hydrogel. Fluorescent images of cross-
sectional views demonstrate that cell viability is not positionally dependent. Cell viability at day 
1 was 76% but significantly increased to 84% by day 14. Cell number, as an indication of cell 
proliferation, increased slightly from the initial cell seeding density of 5×106 cells/mL to 5.5×106 
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cells/mL at day 1, then experienced a significant upward trend to 17×106 cells/mL by day 14 
(Figure 4.10j). For the chondrocytes-laden hydrogel constructs, cell viability increased from day 
1 to 14 (Figure 4.10k). MTT absorption also increased over time, indicating cell growth within 
the hydrogel constructs (Figure 4.10m). 
 
 
Figure 4.10 Fluorescent surface (a, b, e, f) and cross-sectional (c, d, g, h) images of the ATDC5 cell-laden 
hydrogel constructs showing live (green) and dead (red) cells after 1 day (a-d) and 14 days (e-h) of 
culture. Cell viability (i) and cell number (j) for various cell culture periods (1, 14, 28 days). (*p<0.05, 
compared to the cell viability and cell number at day 1 culture, n=3). Cell viability (k), representative live 
cells image of day 14 (l) and MTT assay (m) of embedded primary chick chondrocytes. (*p<0.05, n=3). 
Scale bar (a-h) = 200μm, scale bar (l) = 100μm. 
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4.4.7 Deposition of GAG and Collagen Type II 
        Cell-laden hydrogel constructs generally maintained their structural integrity and original 
shape throughout the culture period (Figure 4.11). The height of cell-laden hydrogel constructs 
decreased with time (Figure 4.11c), probably due to the gel contraction caused by the 
proliferating cells and deposition of ECM. Newly formed ECM was examined using Alcian blue 
staining to visualize GAG (Figure 4.12a, b, c) and immunocytochemistry for Collagen type II 
(Figure 4.12d, e).(48) Alcian blue stained sections demonstrate that cells secreted GAG after 7 d 
of culture. At day 14, cell number increased and more were secreting GAG. At day 28, many 
cells showed GAG deposition and the intensity of Alcian blue staining was higher than that at 
day 7 or day 14. Immunocytochemistry showed obvious expression of Collagen type II at day 14 
and 28. For the chondrocytes-laden hydrogel constructs, Alcian blue and Collagen type II 
immunofluorescence staining reflected secretion of GAG and Collagen type II by primary chick 
chondrocytes, which are two main components of cartilage tissue matrix (Figure 4.12f, g). These 
results demonstrated that porous cell-laden hydrogel constructs fabricated in this study supported 
chondrogenic differentiation and ECM deposition. 
 
 
Figure 4.11 Digital photos of cell-laden hydrogel constructs after 1 (a), 14 (b), and 28 (c) days of culture. 
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Figure 4.12 Accumulation of GAG (a, b, c) and Collagen type II (d, e) in ATDC5 cell-laden hydrogel 
constructs. Expression of GAG was analyzed by Alcian blue staining at day 7 (a), 14 (b) and 28 (c). 
Expression of Collagen type II was analyzed by immunofluorescent staining at day 14 (d) and 28 (e). 
Accumulation of GAG (f) and Collagen type II (g) in primary chick chondrocytes-laden hydrogel 
constructs. Scale bars=100μm. 
 
4.5 Discussion 
        Advances in cartilage tissue engineering (CTE) depend upon reliable chondrogenic cell 
sources, appropriate scaffolds, and favorable culture conditions (e.g. suitable growth factors, 
nutrients and mass transfer) (49). The choice of appropriate scaffolding materials plays a 
fundamental role in successful CTE applications. Hydrogels are particularly attractive as 
scaffolding materials for CTE because their high fluid content closely mimics native ECM and 
they can homogenously suspend cells in a 3D microenvironment; this means that encapsulated 
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cells typically retain a rounded morphology that may facilitate the chondrocytic phenotype (50, 
51). However, fabricating a predesigned external shape and obtaining a porous structure are still 
difficult to achieve due to the high-water content of hydrogels. Control over the scaffold’s 
external shape helps to fill irregular cartilage defects, while the internal pores facilitate effective 
mass transfer. In this study, porous cell-laden hydrogel constructs were produced by a 
bioplotting technique supplemented with a submerged cross-linking technique.  
        Modelling and experimental studies show that cell viability is dependent on the needle type 
employed, with enhanced viability noted for conical needles compared with cylindrical needles 
(20, 52). and thus, a conical needle was used in this study. Linear PEI with a low molecular 
weight has been used in the field of tissue engineering and regenerative medicine to promote 
cells adhesion and proliferation (41) or as a material for tissue-engineered scaffold fabrication 
(42). PEI was used to pretreat the culture plates to promote adhesion of strands to the plotting 
surface since PEI pretreating helped to lower its contact angle and increase the contact area. This 
coating process is an important supplement to the 3D bioplotting technique since it helps to 
anchor the whole bioplotted scaffolds on the plotting surface and avoid possible deformation and 
undesired movement during the layer-by-layer deposition (Figure 4.3). PEI was also an 
indispensable addition in the cross-linking medium. Predesigned structure could not be achieved 
without PEI (Figure 4.3). This is probably due to the electrostatic attraction between the 
dispensed polyanionic SA strands and the polycationic PEI in the cross-linking medium that 
helps to maintain the cylindrical shape of dispensed strands.  
        Notably, small pores observed between deposited layers from the 3D reconstruction and 
optical images indicate that this fabrication technique withstood potential compression issues 
that may occur while depositing strands, thus preserving the space between layers (37). Time-
dependent swelling, in vitro mass loss behavior and compressive modulus of the porous hydrogel 
scaffolds were demonstrated to be tunable by varying the Ca2+ concentration of the cross-linking 
medium. The loss of mechanical properties with time can be explained by alginate dissolution or 
decross-linking by calcium diffusion out of the matrix. The Young's modulus reported here is 
lower than that of articular cartilage (~0.4MPa) (53). This seems to be a common issue attributed 
to the use of the hydrogels (37). To overcome this problem, Malda et al. utilized synthetic 
polymer or printed polymeric microfibers to strengthen the printed hydrogel constructs (54, 55). 
Other researchers focused on employing advanced hydrogel materials to strengthen the 
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mechanical properties of the printed construct or induce embedded cells to secrete more ECM to 
enhance the mechanical properties (56, 57). Based on current results, the mechanical properties 
of printed hydrogel constructs can be improved through future research by designing various 
internal structures or supplementing with other materials.  
         The swelling ratios of the SA-50mM and SA-100mM hydrogels generally decreased over 4 
weeks of incubation probably due to the loss of material from the polymer bulk (e.g., scission of 
the polymer backbone). For the SA-200mM group, decreasing the cross-linking density resulted 
in an increase in the swelling ratio. The decrease of swelling ratio observed after three weeks 
was probably because the influence of hydrogel mass loss on the swelling ratio prevails over the 
influence of reduced crosslinking density. The fabrication of porous hydrogel scaffolds was 
performed under mild conditions (room temperature) and thus proteins can be directly loaded 
into this fabrication system during scaffold production without denaturation. Two mechanisms 
are involved in the protein release from the SA hydrogel scaffolds: (1) proteins are released 
through the polymer network and (2) the rate of protein release increases with degradation of the 
polymer network (58). The latter is not thought to be a suitable method as it may lead to a burst 
release of the protein (59). Here, 80% of the BSA was released over 48h by the SA-50 and SA-
100mM groups; the protein was released a little more slowly by the SA-200mM group. The mass 
loss of hydrogel scaffolds was around 10% after 1 week, which means that the BSA was released 
from the hydrogel scaffolds mainly through the polymer network. The fast protein release was 
probably because the low alginate concentration and the high-water content expedite the 
diffusion and transfer of the protein. Therefore, the protein release kinetics might be tuned by 
varying the polymer concentration or the initial cross-linking density. Given the mild fabrication 
conditions, other advanced materials or techniques could be incorporated in our biofabrication 
system to optimize the protein release profile.  
        The relatively low cell viability at day 1 could be due to the shear forces and inlet pressure 
applied to the cells when mixing with the SA solution or during dispensing. Despite the loss of 
cells during the embedding and bioplotting processes, the cell viability significantly recovered 
after 14 days of culture due to significant cell proliferation, as indicated by the higher cell 
viability compared to day 1(Figure 4.10i). Moreover, histology and immunocytochemistry 
results clearly demonstrate the deposition of cartilage ECM including GAG and collagens, which 
can create an integrated and dense network that forms the basis for the biomechanical properties 
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of articular cartilage (60). These results clearly demonstrate that this bioplotting-based 
fabrication technique is well suited for the bioprinting of living cells and supports chondrogenic 
cell differentiation.  
        Notably, a 2% polymer concentration was used in this study. Low viscosity increases the 
difficulty of fabricating the liquid gel precursors into hydrogel scaffolds, and mastering of a low 
viscosity fabrication technique would be of great help to future study. Previous studies increased 
the polymer concentration to improve the printability of the hydrogels. However, cells thrive best 
in a relatively aqueous environment, in which their migration and matrix deposition is not 
limited by the dense polymer network. The biofabrication technique introduced here enabled 
successful production of porous cell-laden hydrogel constructs from hydrogel precursors with a 
relatively low polymer concentration, which may be more desirable for the encapsulated cells. 
This biofabrication technique can also be considered as a versatile biofabrication platform that is 
compatible with various soluble biomaterials and growth factors (GF) and has various tunable 
properties (e.g., swelling, mechanical properties, degradation, GF release profile) that are 
relevant for potential applications in cartilage tissue engineering and regenerative medicine. 
 
4.6 Conclusion 
        This study reports a facile bioplotting-based fabrication technique for the production of 
mechanically stable porous hydrogel scaffolds or cell-laden hydrogel constructs. Various 
properties including swelling ratio, in vitro degradation behavior, protein release profile, and 
mechanical properties can be tuned by controlling the Ca2+ concentration in the cross-linking 
medium. This biofabrication technique and the porous hydrogel scaffolds obtained can support 
high cell viability and deposition of cartilaginous ECM. The technique might also be compatible 
with various soluble biomaterials and GFs due to its hydrophilic nature. As such, this 
biofabrication technique is a versatile platform with potential applications to cartilage tissue 
engineering.  
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Chapter 5: Characterization of calcified cartilage matrix formation in 
homogeneous hydroxyapatite/alginate hydrogel and its printability 
 
This chapter has been finished and ready for submission as You, F., Chen, X., Cooper, D., 
Eames, B. Characterization of calcified cartilage matrix formation in homogeneous 
hydroxyapatite/alginate hydrogel and its printability. 
 
5.1 Abstract 
        Calcified cartilage formation plays an important role in a successful cartilage repair. 
However, a layer of calcified cartilage has not formed by current cartilage tissue engineering 
(CTE) strategies. To mimic native calcified cartilage, we hypothesized that the homogenously 
dispersed hydroxyapatite (HAP) within alginate (ALG) hydrogel promotes the deposition of 
characteristic matrix of calcified cartilage including Collagen type X and mineralized matrix. To 
test this hypothesis, a dispersant-sodium citrate (SC) was added to achieve homogenous mixing 
of HAP within ALG. Cell growth, extracellular matrix (ECM) production, and mineralization 
potential were evaluated in the presence or absence of HAP particles. Chondrocytes in gels with 
higher HAP content had higher mineralization potential, Collagen type X and minerals 
deposition. The printability of the composite hydrogel precursors was verified by printing porous 
scaffolds using a 3D Bioplotter. The results herein demonstrated that the presence of HAP in 
ALG hydrogel facilitates the deposition of calcified cartilage extracellular matrix (ECM) and 
thus is a promising design strategy for osteochondral interface regeneration.  
 
Key words: calcified cartilage; hydroxyapatite; alginate; Collagen type X; minerals 
 
5.2 Introduction  
        Osteoarthritis (OA) is a degenerative joint disorder characterized by articular cartilage 
lesions, severe joint pain, and loss of joint function (1). Surgeries are typically needed to treat 
OA due to the limited self-repair tendency of cartilage (2). Current surgical intervention such as 
autologous chondrocyte implantation (3), microfracture (4), osteotomy (5), joint replacement (6) 
are usually associated with donor site morbidity, undesirable fibrocartilage formation, or poor 
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long-term outcomes (7, 8). Cartilage tissue engineering (CTE) has shown promising to repair 
cartilage defects (9-11). Nevertheless, most current CTE strategies have not achieved successful 
regeneration of the osteochondral interface between the engineered cartilage and the subchondral 
bone. Although engineered osteochondral constructs have been explored to regenerate 
osteochondral defects (defects extending from articular cartilage to underlying subchondral 
bone), a stable osteochondral interface has yet to be formed within the construct. Notably, a layer 
of osteochondral interface is crucial for sustaining the structural integrity of engineered cartilage 
by curtailing ectopic mineralization and bone upgrowth, and preventing vascular invasion from 
bone in the full-thickness defects (12, 13). The native osteochondral interface consists of a layer 
of calcified cartilage, in which hypertrophic chondrocytes are embedded in a mineralized 
cartilage matrix. As an osteochondral interface, calcified cartilage also transmits force from 
pliable cartilage to stiff bone and serves as a structural barrier between cartilage and subchondral 
bone to ensure the pressurization of articular cartilage. As the last layer of cartilage next 
the bone, calcified cartilage also maintains the integrity of the osteochondral connection when 
compressive, tensile, and shear forces are transmitted from the viscoelastic joint cartilage to the 
stiff mineralized subchondral bone. The ideal scaffolding materials for osteochondral interface 
regeneration should promote the deposition of calcified cartilage matrix.  
        Formation of Collagen type X and mineralized matrix within scaffolds is the key to 
regenerating calcified cartilage. Previous results demonstrated the formation of Collagen type X 
with chondrocytes cultured directly on a calcium phosphate substrate (14). Also, published data 
indicated that cellular uptake of Ca2+ and inorganic phosphate (Pi) appeared to lead to the 
formation of complexes of amorphous calcium phosphate by chondrocytes (15). Inspired by 
these results, the present study employed hydroxyapatite (HAP) as a cue to induce the secretion 
of calcified cartilage matrix from chondrocytes. Alginate (ALG) hydrogels are cross-linked 
polymer networks holding large amounts of water and are good candidates for soft tissue 
engineering (16) due to their properties including efficient mass transfer, stimuli-responsiveness 
(17) and hydrophilic nature. HAP is widely present in natural mineralized tissue (18). 
Incorporating inorganic particles in polymeric hydrogels has been done before and is expected to 
introduce bioactive characteristics to the cross-linked network (19). Based on these findings, this 
study was aimed at designing and optimizing a composite ALG/HAP scaffold for calcified 
cartilage regeneration. Herein we hypothesize that the homogenously dispersed HAP within 
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ALG hydrogel promotes the deposition of characteristic matrix of calcified cartilage including 
Collagen type X and mineralized matrix. 
        Most common approach used to synthesize ALG/HAP composite is direct mixing hydrogel 
with hydroxyapatite particles (20, 21). However, such a physical mixing process is uncontrolled 
and usually leads to inhomogeneity of particle dispersion within polymer matrix. The 
heterogeneous distribution of these particles has a negative influence on experiment repeatability 
and not all embedded cells have access to mineral particles. Therefore, homogenization and 
intermixing of inorganic components within the polymeric networks remains a major 
engineering challenge for developing an ALG/HAP composite hydrogel.  
        An important objective of this study is, by exploiting a dispersant, the homogenous 
dispersion of mineral particles in hydrogel matrix can be achieved. Dispersants have been widely 
used for the stabilization of particle dispersion during ceramic processing (22, 23). Another 
advantage of even distribution of ceramic particles in hydrogel is facilitating 3D printing process. 
During the fabrication process, hydrogel precursors are usually stored in a syringe and ready to 
flow through a needle tip. Inhomogeneous dispersion of nanoparticles may lead to sedimentation 
of inorganic components and thus clog the needle tip.  
       In the current study, homogenous ALG/HAP composite hydrogels were prepared using a 
dispersant-sodium citrate (SC). Embedded chondrocyte viability, characteristic calcified cartilage 
matrix including Collagen type X and mineralized matrix were studied. In the end, porous 
ALG/HAP composite hydrogel scaffold will be fabricated by a 3D Biopoltter to verify the 
printability and dispersion outcomes of the ALG/HAP hydrogel system. 
 
5.3 Materials and Methods 
5.3.1 Cells Isolation and Culture 
        Primary chondrocytes were isolated from cartilaginous sternums of 14-day-old chick 
embryos (24). Chondrocytes from embryonic chick cartilage were used as the cells source due to 
the accessibility and abundant numbers and they also have been very well understood and 
characterized in terms of development and differentiation in tissue scaffolds under different 
culture conditions (25-29). A dozen of chick embryos were used to obtain sufficient numbers of 
primary cells without passaging them to minimize negative effects of monolayer passaging on 
chondrogenic differentiation. The sternums of chick embryos were carefully excised, chopped 
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and placed in digestion medium consists of 0.2% collagenase and 0.25% trypsin in Hank’s 
buffered salt solution (HBSS) at 37℃ and 5% CO2 for 2 hours. The digestion was terminated by 
adding Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% FBS. 
The obtained cell suspension was filtered through a 70 µm sterile Nitex and centrifuged at 200g 
for 10 minutes. The collected cell pellets were suspended and cultured in culture medium 
containing DMEM, 10% FBS, 2mM glutamine, 0.1 mg/mL kanamycin, 1% AA (100 U/mL 
penicillin, 0.1 mg/mL streptomycin, 0.25 µg/mL amphotericin B), and 0.01 mg/mL ascorbate.  
The cells were harvested at confluence by trypsinization and collected by centrifugation at 300 g 
for 10 min, followed by counting the cell number using a hemocytometer. 
 
5.3.2 Synthesis and Characterization of Hydroxyapatite (HAP) Suspensions with the Addition of 
Dispersants 
        Sodium citrate tribasic dihydrate (SC, Na3C6H5O7·2H2O, Sigma-Aldrich) was added to 
DMEM. HAP particles were mixed into the SC-incorporated DMEM with the molar ratios of SC 
to HAP were 0.1:1, 0.125:1, 0.25:1, 0.5:1, 1:1, 2:1, 4:1, 8:1, 10:1 to determine the optimum ratio. 
The pH of the suspensions was measured using a standard pH meter (Pinnacle M530). The Zeta-
potential of the suspensions was determined in triplicate using a Zetasizer (Brookhaven). 
Sedimentation characteristics of the prepared suspensions were monitored by adding 10 ml of 
suspension in 15 ml tubes and recording the settling height. For transmission electron 
microscopy (TEM), HAP suspensions with/without dispersants dropped onto a carbon-coated 
copper TEM grid and examined (Philips CM10). ALG/HAP composite hydrogel precursors were 
prepared by dissolving ALG in HAP suspensions in the absence or presence of SC. To examine 
the dispersion of the incorporated HAP particles in ALG matrix, ALG and HAP hydrogel 
precursors were lyophilized, coated with gold and examined by scanning electron microscopy 
(SEM, SU6600, HITACHI) equipped with energy dispersive spectroscopy (EDS). The elemental 
2D-mapping of calcium and phosphorus was examined by EDS technique. 
 
5.3.3 Preparation and Culture of Cell-laden ALG/HAP Composite Hydrogel Disks 
        SC was dissolved in DMEM and the obtained medium was filtered through a 0.22μm filter 
for sterilization. HAP suspensions were prepared in the SC-incorporated DMEM. ALG solution 
solutions were prepared by stir-bar mixing of alginic acid sodium salt in HAP suspensions under 
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sterile condition. The ALG/HAP solution was then mixed with cells suspension with a volume 
ration of 7:3 (solution volume to cells suspension) to reach a final cell density of 1.57×106 
cells/ml. Three groups of samples were obtained: i) ALG, ii) ALG+1%HAP, and iii) 
ALG+2%HAP. ALG concentration was kept at 2.5% in all groups. Corresponding acellular 
controls for each group were prepared. 24-well culture plates were washed with DMEM prior to 
use. 1-ml syringe was used to inject 120μL cell/gel mixture to each well and waited until the 
mixture evenly cover the bottom of well which usually took 15-20 minutes. 1mL DMEM was 
added into each well followed by crosslinking ALG/HAP solutions with autoclaved 1mL 100 
mM calcium chloride solution for 10 minutes. The crosslinking solution was replaced by culture 
medium and then culture plates were cultured in incubator at 37℃.                   
 
5.3.4 Cell Viability and Proliferation 
        Cell viability tests were conducted using calcein AM and ethidium bromide (EthD-1) 
solution (live/dead viability kit, Invitrogen) as recommended by the supplier. At each time point, 
cell-laden hydrogel scaffolds were removed from culture, washed with DMEM and incubated in 
2µM calcein-AM and 1 µM EthD-1 solution in DMEM for 30 min at 37 ℃. The samples were 
washed with DMEM and imaged using a fluorescence microscope (Leica, Switzerland). 
Sequential images at different locations were captured to visualize cell distribution and viability 
of the embedded cells within the hydrogel. To quantitatively determine the cell viability, the 
stained cells were released by incubating cell-laden constructs in 50mM EDTA (diluted in 
DMEM) for 30 min at room temperature. Then the medium was pipetted to obtain an 
homogenous cell suspension mixture. Samples (n=3) were taken from the mixture of each disk 
and imaged under a coverslip on a glass microscope slide at 5-6 random locations to count live 
and dead cells. Cell number (n=3) was calculated using a hemocytometer to indicate the cell 
proliferation over the culture period. 
 
5.3.5 Cartilaginous Matrix Deposition  
        Alcian blue staining was used to detect accumulation of glycosaminoglycans (GAGs) in the 
cell-embedded disks. The cell-embedded disks (n=3) were removed from culture, washed with 
DMEM and fixed in acetone and methanol solution (1:1) on ice for 15 minutes and then stained 
with 0.001 % Alcian blue in 3% acetic acid solution overnight. The stained constructs were 
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washed with 25% ethanol in 3% acetic acid for 1h and then washed with 50% ethanol in 3% 
acetic acid until obtaining a good background, and imaged using light microscopy. 
        Immunofluorescent staining was performed to detect the deposition of Collagen type II or 
Collagen type X. The disks (n=3) were harvested and washed with DMEM and fixed in 4% 
paraformaldehyde (PFA) in PBS at 4ºC on a shaking platform. The fixed samples were 
permeabilized with 0.5% Triton X-100 in PBS (PBS-T) for 5 min three times with shaking, 
followed by pre-treatment to block nonspecific reactions with blocking buffer (4% goat serum 
and 2% sheep serum in PBS-T) 2 hours while shaking at room temperature. For collagen 
staining, the constructs were incubated in anti-Col2 or anti-Col10 antibody (DSHB) in blocking 
buffer (1:100) overnight at 4ºC while shaking followed by rinsed with blocking buffer (30). The 
secondary immunoreaction was carried out with Alexa 488-conjugated goat anti-mouse IgG 
(1:1000, Invitrogen) in blocking buffer overnight at 4ºC, followed by rinsing with PBS-T. 
Fluorescent images were taken with a fluorescence microscope (Leica).   
        ImageJ was used to quantitatively analyze calcified cartilage matrix deposition (31). Four 
random regions of interest covered by Alcian blue and immunofluorescent stains were taken for 
each disk and appropriate threshold was applied to segment the stained areas (same threshold for 
all samples). For each time point, such segmentation was carried out to estimate the area covered 
by staining compared to the total area in the regions of interest.  
 
5.3.6 Mineralization 
        Mineralization potential was quantitated by measuring alkaline phosphatase (ALP) activity, 
which was determined using an enzymatic assay based on the hydrolysis of p-nitrophenyl 
phosphate (pNP-PO4) to p-nitro-phenol (pNP). Briefly, the samples were lysed in 0.1% Triton-X 
solution for 15 min at 4ºC, then were added 50μL pNP-PO4 solution (Sigma) and allowed to 
react for 30 min at 37ºC. The reaction was stopped with 20μL 0.1 N NaOH (Sigma), and sample 
absorbance was measured at 405 nm using a microplate reader. ALP staining was done as 
follows.  Samples were fixed in 4%PFA in PBS for 10 min and washed for 5 min in ALP buffer 
(100 mM Tris, pH 9.5; 50 mM MgCl2; 100 mM NaCl; 0.1% Tween 20), and incubated in BM 
Purple (Roche, USA) until strong signal appeared.  
        Mineral distribution was evaluated with Alizarin Red staining. Briefly, cell-embedded disks 
were fixed in 4% PFA for 20 min at room temperature. After PBS washing, disks were stained 
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with 0.1% Alizarin Red solution (pH=4.3) for overnight at ambient temperature and imaged with 
a Nikon optical microscope. 
 
5.3.7 Rheology of Composite Hydrogel Precursors 
        Rheological properties of three groups of hydrogel precursors (2.5%ALG, 
2.5%ALG+1%HAP, 2.5%ALG+2%HAP) were measured using a rheometer (AR G2, TA 
Instruments). Viscosity and shear stress were measured at 25 °C with a rotatory test setup by 
varying the shear rate from 0 to 200 1/s. Storage (G') and loss modulus (G'') were assessed by 
oscillatory tests by applying 5% strain within the linear viscoelastic region over a frequency 
range between 1 and 100 rad/s. 
 
5.3.8 3D Printing of Composite Hydrogels 
        12-well tissue culture plates were pre-treated with sterile 0.1% (w/v) polyethylenimine 
(PEI, Alfa Aesar, MW: 60000) in PBS and incubated overnight at 37 °C. The PEI-doped plotting 
surfaces were flushed with double distilled water prior to fabrication. To form the composite 
hydrogel scaffolds, hydrogel precursor solutions were loaded into the low temperature 
dispensing head of the 3D-BioplotterTM (EnvisionTec, GmbH, Gladbeck, Germany). 3D porous 
scaffolds were produced by a sequential fiber deposition process. Briefly, the Bioplotter operates 
as a three-axis dispensing machine that deposits hydrogel precursors pneumatically on a 
stationary platform following the CAD model which contains the information for the layer-by-
layer deposition (32). The gel precursors were dispensed through a 200 µm conical needle, using 
0.02MPa pressure at dispensing speed of 8.5 mm/sec into a crosslinking medium containing 
100mM calcium chloride, 0.1 % w/v PEI on the 0.1 % w/v PEI/PBS pretreated culture plate (30). 
By a layer-by-layer deposition process, scaffolds of 10mm×10mm×3.6mm with 20 layers of 
strands and 1 mm strand spacing were created. 
 
5.3.9 Micro-CT Characterization of Printed Porous Hydrogel Scaffolds 
        Micro-CT imaging of printed composite hydrogel scaffolds was conducted by a Bruker 
micro-CT SkyScan 1172 (Kontich, Belgium) scanner. Samples were scanned with acquisition 
protocol that consisted of pixel size of 19.97 μm, X-ray tube settings of 40 kV and 250μA, 
rotation step of 0.1°, 1 mm aluminum filter, 10-frame averaging. Isotropic 2D slices of the 
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scaffolds were acquired from the projection datasets in a reconstruction procedure using 
NRECON V 1.6.10.1 (Skyscan 2011). The obtained data were exported into Amira software 
(Amira, USA) for 3D reconstruction. 
 
5.3.10 Statistical Analysis 
        For quantitative analysis, Student's t tests were used to assess differences between two 
groups and multiple comparisons were performed via one-way ANOVA using SPSS software. 
Data are expressed as mean values ± standard deviation (SD), with p values <0.05 considered 
statistically significant. 
 
5.4 Results 
5.4.1 SC Can be Used to Stabilize HAP Suspensions 
        Sedimentation experiments were carried out to evaluate the effect of different molar ratios 
of SC to HAP on the stabilization of the HAP suspensions (Figure 5.1). SC can reduce 
sedimentation of HAP suspensions for the first 24h while the sedimentation of reference group 
without dispersant can be observed after 3h (Figure 5.1B, C). Stable suspensions without 
demarcation line for 24h were obtained when the molar ratio of SC to HAP was 0.25:1 or higher. 
Corresponding Zeta-potential measurements were carried out to reveal electrical charge on the 
HAP particles and the stability of HAP dispersions (Figure 5.1E). Overall, addition of SC led to 
an obvious increase in the negative Zeta-potential from values of +1 mV without SC to about -26 
mV with a molar ratio of 10:1 (SC to HAP). pH values were tested to investigate the influence of 
SC on the pH. With the addition of SC, pH value suspension can go up to 9.4 when the molar 
ratio (SC: HAP) reach 10 (Figure 5.1F). TEM micrographs showed the morphology and 
dispersion state of the HAP particles in the absence (Figure 5.2A) or presence with SC (Figure 
5.2B, the molar ratio of SC to HAP is 0.25:1). HAP spherical crystals were recognized in both 
groups with the size of 150-200 nm in diameter. The aggregation of particles was more obvious 
in the absence of SC while the HAP particles in the other group were well dispersed. 
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Figure 5.1 Influence of SC concentration on the stabilization of HAP suspensions. (A-D) Sedimentation 
behavior of HAP suspensions supplemented with SC. (E) Zeta-potential of HAP suspension in water as a 
function of SC addition. (F) pH of HAP suspension in DMEM as a function of SC addition. 
 
 
Figure 5.2 TEM micrographs of HAP particles in the absence (A) or presence (B) of SC. 
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5.4.2 Dispersion of HAP Particles in ALG Hydrogel is Analyzed by SEM 
        SEM micrographs and corresponding EDS analysis of composite hydrogel precursors were 
performed (Figure 5.3) to visualize the dispersion of HAP particles within the ALG hydrogel. 
The globular particles in the alginate matrix can be observed in groups with HAP (Figure 5.3D-
E). However, the number and size of these globular particles in composites with dispersants 
(Figure 5.3C, E) were less and smaller than those without dispersants (Figure 5.3B, D), 
indicating that the addition of SC reduced the aggregation of HAP particles and promoted their 
dispersion in the alginate matrix. The heterogeneity of HAP particles in SC-free composites and 
the homogeneity of composites with SC were also confirmed by elemental mapping for calcium 
and phosphorus elements, both of which existed in HAP molecules. The distribution of calcium 
and phosphorus elements were very heterogeneous in SC-free groups (Figure 5.3G, I, L, N), 
suggesting the aggregation of HAP particles. In contrast, the elements distribution in composites 
with SC were nearly homogeneous and no obvious aggregation of calcium and phosphorus 
elements (Figure 5.3H, J, M, O), revealing that clustering of HAP particles in ALG matrix can be 
avoided by using SC. 
 
Figure 5.3 SEM micrographs and corresponding calcium and phosphorus mapping of three groups show 
the dispersion of HAP particles in ALG hydrogel. 
 
5.4.3 Influence of the Addition of HAP Particles on Cytocompatibility 
        To ensure that the whole fabrication process and materials involved could provide a 
cytocompatible environment for chondrocytes, live and dead cells were visualized in composite 
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hydrogels. Fluorescent images showed most chondrocytes were alive and it can be recognized 
that a homogeneous distribution of encapsulated cells was achieved. All three groups showed a 
higher cell viability than 75% throughout culture period. The cell viability of ALG+1%HAP at 
Day14 was significantly higher than that of Day1 and meanwhile, same trend was observed for 
the group of ALG+2%HAP. Quantitative analyses suggested that cell numbers steadily increased 
during the culture period for each group, each showing a significant increase in cell number 
compared with earlier culture time points. At each timepoint, chondrocytes cultured in three 
composite hydrogels showed similar cell numbers during culture period.  
 
 
Figure 5.4 Fabrication process and materials supported cell survival and proliferation. (A) Fluorescent 
images showing live (green) and dead (red) cells. (B) Cell viability (*p<0.05, n=3) and (C) cell number 
for various cell culture periods. At each timepoint, there is no significant difference in cell numbers 
among three groups. For each group, chondrocytes numbers increase significantly with culture (n=3). 
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5.4.4 Chondrocytes Secrete Cartilage Matrix within the Composite Hydrogel Disks 
        The addition of HAP phase into the ALG hydrogel did not have a significant effect on the 
chondrocytes viability and proliferation. Then, the influence of HAP presence on the cartilage 
matrix secretion was analysed. Alcian blue and Collagen type II immunofluorescence staining 
were used to detect the deposition of the two main components in cartilage ECM, 
glycosaminoglycans (GAGs) and Collagen type II, within the composite hydrogel disks during in 
vitro culture. Alcian blue staining demonstrating the GAGs synthesis was recognized around 
cells in all groups throughout in vitro culture. Less and smaller stained areas were seen at Day7 
for three groups of composite hydrogels (Figure 5.5A, B, C). At Day14 and 28, areas of Alcian 
blue-stained matrix appeared to increase in numbers (Figure 5.5D, E, F) and size (Figure 5.5G, 
H, I) for all three groups. Relative area of Alcian blue-stained matrix was measured to quantitate 
these observations, and the results agreed with the trends observed in the images. Alcian blue-
stained matrix increased over time for all three groups, being significantly higher at Day28 
compared to Day 7 and 14 (Figure 5.5J). At Day 14, ALG+2%HAP showed least regions of 
Alcian blue-stained matrix than other two groups (Figure 5.5J). At Day28, ALG+2%HAP 
showed significant less Alcian blue stained area than that of ALG group. 
        Immunostaining showed the secretion of Collagen type II matrix around embedded cells in 
composite hydrogel disks after 28 days of culture for three groups (Figure 5.6). ALG group 
seemed to have less collage type II stained matrix than the other groups (Figure 5.6A, B, C). 
Embedded chondrocytes appeared to show comparable synthesis of Collagen type II for groups 
of ALG+1%HAP and ALG+2%HAP (Figure 5.6B, C). Quantitive analysis revealed the same 
trends observed in the staining images (Figure 5.6D). These results indicated that composite 
hydrogels offered a advantageous environment for chondrogenic differentiation and increased 
synthesis of cartilaginous ECM over long in vitro culture periods. 
        To test the hypothesis that the presence of HAP phase promotes synthesis of Collagen type 
X, the deposition of Collagen type X was detected by immunostaining at Day28. It can be 
observed from the images that Collage type X secretion increased with the amount of HAP phase 
addition (Figure 5.7A, B, C). Quantitate analysis demonstrated that chondrocytes in composite 
hydrogels with the presence of HAP phase secreted more Collagen type X than ALG group, and 
the amount of synthesized Collagen type X was positively related with content of added HAP 
phase. Therefore, the addition of HAP particles did induce the secretion of Collagen type X.       
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Figure 5.5 Composite hydrogels provide a favourable envirnment for increased synthesis of GAGs. (A) 
Increased secretion of Alcian blue-stained matrix in different gel disks over in vitro culture time (Scale 
bar=200μm). (B) Quantitative increase of Alcian blue-stained matrix over in vitro culture time for each 
group (*p<0.05, n=4).  
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Figure 5.6 Collagen type II immunofluorescence staining demonstrates the deposition Collagen type II in 
(A)ALG, (B) ALG+1%HAP, (C) ALG+2%HAP composite gel disks after 28 days of culture (Scale 
bar=200μm). (C) shows the quantitation of Collagen type II immunostained area in gel disks after 28 days 
of culture (*p<0.05, n=4). 
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Figure 5.7 Collagen type X immunofluorescence staining demonstrates the deposition Collagen type X in 
(A)ALG, (B) ALG+1%HAP, (C) ALG+2%HAP composite gel disks after 28 days of culture. (C) shows 
the quantitation of Collagen type X immunostained area in gel disks after 28 days of culture (*p<0.05, 
n=4). 
 
5.4.5 Minerals Deposition Increases with HAP Content 
        Mineralization potential of chondrocytes in composite hydrogels was determined by ALP 
activity. After two weeks of culture, chondrocytes in the ALP+1%HAP and ALP+2%HAP 
scaffolds showed positive ALP staining while no obvious ALP staining was seen in ALG group 
(Figure 5.8A, B, C). At Day28, although ALP staining can be observed in all three groups, 
chondrocytes in ALP+1%HAP and ALP+2%HAP gels secreted more ALP (Figure 5.8D, E, F). 
ALP activity measurements indicated similar phenomenon, with ALP+1%HAP and 
ALP+2%HAP measured significantly higher ALP activity as compared to the ALP group and the 
highest ALP activity found in the 2% HA group (Figure 5.8G). 
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        Alizarin red staining was applied to detect the mineral phase synthesized by embedded 
chondrocytes. During 14 days of culture, Alizarin red stained the cells and reflected the cells 
proliferation (Figure 5.9G-L). At Day28, obvious mineral deposition was observed for groups of 
ALG+1%HAP and ALG+2%HAP (Figure 5.9M, N, O). Control groups without cells were also 
stained to investigate the influence of pre-incorporated HAP particles on the Alizarin red staining 
outcomes (Figure 5.9A-F). Results have shown that these HAP particles were not stained by 
Alizarin red. Therefore, positive Alizarin red staining in ALG, ALG+1%HAP and 
ALG+2%HAP groups was mainly from cells and newly formed minerals. Compared with ALG, 
stronger staining in ALG+1%HAP and ALG+2%HAP at Day28 was a result of minerals 
deposited by chondrocytes. Quantitative characterization suggested the same results that 
ALG+1%HAP and ALG+2%HAP groups showed the highest amount of minerals secretion at 
Day28 (Figure 5.9P). This tested the hypothesis that the presence of HAP induced the 
chondrocytes secreted minerals.  
 
Figure 5.8 Mineralization potential was characterized by ALP staining and activity. ALP staining of three 
groups of composite hydrogels at Day 14 (A, B, C) and Day 28 (D, E, F). (G) ALP activity of 
chondrocytes in three groups of composite hydrogels at Day 14 and Day 28. For each group, there was 
significant difference of ALP activity between two time points. For each timepoint, there was significant 
difference among three groups.  
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Figure 5.9 Alizarin red staining detected minerals deposition of ALG, ALG+1%HAP, and ALG+2%HAP 
groups. (A-O) Mineral deposition by encapsulated chondrocytes in three groups of hydrogels were stained 
by Alizarin red staining. (P) Quantitative increase of Alizarin red-stained matrix over in vitro culture time 
for each group (*, +, # p<0.05, demonstrating significant difference over time for same group, *p<0.05, 
demonstrating significant difference between different groups at day 28, n=4).  
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5.4.6 Printability of Composite Hydrogel Precursors is Verified by Successful Printing of 
Composite Hydrogels Scaffolds 
        3D printing possesses unique advantages to fabricate porous hydrogel scaffolds and it relies 
on the printability of the hydrogel precursors. Printability refers to the ability of materials to be 
printed to form and maintain a 3D construct with fidelity and integrity (33). Herein, we tested 
rheology to verify the printability of composite hydrogel precursors and successfully printed 
composite hydrogels scaffolds. Hydrogel precursor viscosity will greatly impact the fiber 
deposition and subsequent scaffold fabrication process. The shear rate dependent behavior of 
composite hydrogel precursor was provided for increasing HAP concentration, suggesting the 
non-Newtonian liquid behavior (Figure 5.10). All composite hydrogel precursors showed the 
shear thinning behavior, and viscosity increased with HAP concentration (Figure 5.10). Then, the 
ALG and ALG+1%HAP composite hydrogel precursors were loaded into bioprinter to print 
porous scaffolds by a layer-by-layer manner (Figure 5.11). To visualize the mineral particles 
dispersion and porous structure, printed scaffolds were analysed by micro-CT. It can be clearly 
seen from micro-CT images that the porous structure of the scaffold was completely 
interconnected for ALG and ALG+1%HAP groups. Thresholding is a method for image 
segmentation and can be used to create binary images (34). By changing the threshold value, 
materials with different density can be visualized. Porous structure is clearly observed when 
setting the threshold value at 90/255. For ALG+1%HAP group, even dispersion of mineral 
particles was clearly spotted when increasing the threshold value (Figure 5.11).  
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Figure 5.10 Viscosity of the three hydrogel composites with the addition of SC showed their shear 
thinning behavior. 
 
 
Figure 5.11 Digital pictures and micro-CT reconstruction of ALG and ALG+1%HAP hydrogel scaffolds. 
HAP particles are evenly dispersed in 3D-printed composite hydrogel. Digital pictures (A, F) and micro-
CT reconstructions of ALG only (3D reconstructions: B-E; reconstructed slices: B'-E') and ALG+1%HAP 
(G-J, G'-J') scaffolds showed the porous structure of hydrogel scaffolds. Even dispersion of HAP particles 
was visualized by increasing the threshold value of reconstruction images for ALG+1%HAP group (G-J, 
G'-J'). 
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5.5 Discussion 
        The goal of this study is to design and prepare ALG+HAP composite hydrogels for the 
formation of a calcified cartilage matrix. To achieve this goal, HAP particles need to be evenly 
dispersed within the alginate hydrogel matrices. It is also hypothesized that the homogenously 
dispersed HAP within ALG hydrogel promotes the deposition of characteristic matrix of 
calcified cartilage including Collagen type X and mineralized matrix. In the present study, HAP 
particles were well dispersed into alginate hydrogels with the addition of a surfactant-SC. The 
response of primary chick chondrocytes in ALG hydrogel with and without HAP was evaluated 
over time to test the hypothesis.  
        The HAP phase was stabilized and homogenously distributed in the aqueous solution by 
adding SC. The effect of SC on the stabilization of HAP suspensions was monitored by 
characterizing the sedimentation behavior. When increasing the molar ratio (SC to HAP) to 0.25 
or higher, the HAP can be stabilized in the aqueous solution for at least 3 days (Figure 5.1). The 
stabilization effect of the dispersant is usually based upon the repulsive forces resulting from the 
adsorption of materials on the surface (stabilization by steric hindrance) and/or the overlapping 
of electrical double layers (electrostatic stabilization) (35, 36). Zeta-potential measurements of 
HAP suspensions showed that the electrical charge on the HAP nanoparticles was close to zero 
in the absence of SC. Therefore, there is no electrostatic repulsive forces could be able to 
counteract the attractive vander Waals forces among HAP crystals in suspension, which explains 
why HAP suspensions precipitated within 3h. Negative zeta-potential went up with the increase 
of SC in the HAP, demonstrating a strong initial increase during low SC concentrations ranges 
followed by a gradual increase at relative high SC concentration ranges (Figure 5.1E). By 
negatively charging HAP nanoparticles, electrostatic repulsive forces were established between 
these particles and in this way the HAP nanoparticles were very well dispersed in the medium. 
The critical molar ratio (SC to HAP) of 0.25 was necessary to stabilize the HAP suspensions, 
which corresponds a Zeta-potential of around -20 mV. The pH value varies from 7 to 7.5 when 
the molar ratio was lower than 0.25. A higher molar ratio than 0.25 would alkalize the 
suspension beyond the physiological level. Therefore, 0.25 was set as a critical molar ratio of SC 
to HAP for subsequent experiments.  
        It was also found that HAP phase was well dispersed in the alginate hydrogels. The 
dispersion state of HAP phase within the alginate hydrogel was examined by SEM and EDS. 
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Results showed that SC prevented the aggregation of the mineral phase within the alginate 
matrix at a SC/HAP molar ratio of 0.25, despite the increased HAP content. The stabilizing 
effect of HAP particles is not only attributed to the SC absorption on HAP particles, but also the 
alginate matrix, which is negatively charged at physiological pH owing to its isoelectric point of 
5.4. The repulsions between alginate and negatively charged HAP crystals could increase the 
stability and dispersion of HAP in alginate matrix. 
        Cytocompatibility of composite hydrogels was evaluated by cell viability and proliferation. 
The addition of HAP particles into alginate hydrogels did not impair the cell viability. There was 
no significant difference in cell viability among three groups at Day1 and Day7. Cell viability of 
ALG was generally kept at similar level over culture period and live cells of both ALG+1%HAP 
and ALG+2%HAP groups demonstrated an increase from Day1 to Day14. This probably 
because cell viabilities recovered from initial cell viability, which might have been decreased by 
the increased stress exerted on cells from the mixing of mineral particles.     
        Embedded chondrocytes in all three groups displayed abundant synthesis of cartilage ECM. 
Alcian blue staining and Collagen type II immunostaining in three groups reflected the secretion 
of two major components of cartilage ECM, GAG and Collagen type II, further indicating the 
biocompatibility of composite hydrogels and preparation method. The addition of HAP into 
ALG hydrogels negatively influenced the GAG biosynthesis of chondrocytes at Day28. This was 
consistent with previously published research demonstrating decreased proteoglycan content 
may happen during cartilage mineralization (37).  
        All three groups expressed Collagen type X after 28 days of culture, which is a 
characteristic of calcified layers of articular cartilage (38, 39). It has been shown that after long 
time culture, embedded chondrocytes in alginate hydrogels would express Collagen type X (24), 
which was in accordance with the finding in the ALG group of the present study. Moreover, it 
was also found that the amount of newly formed Collagen type X was positively correlated with 
the content of added HAP. This was probably because HAP served as a reservoir of ions such as 
Ca2+ and Pi. It has been suggested that the exogenous Ca2+ and Pi markedly influenced Collagen 
type X synthesis (40-42). 
        It was observed that chondrocytes in ALG+1%HAP and ALG+2%HAP exhibited higher 
ALP activity than chondrocytes in ALG only group. The elevated mineralization potential 
observed here for groups with HAP addition were in accord with published research (43). ALP 
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activity showed a significant decrease from Day14 to Day28 which may be due to its 
normalization to cell numbers. ALP positive staining was observed in three groups at Day14, 
while stronger staining was seen in samples with the addition of HAP particles. Intense ALP 
staining can be observed at Day28 for three groups of composite hydrogels. The change in 
mineralization potential of chondrocytes were probably due to the presence of HAP particles. 
HAP can serve as a mediator that facilitated cell-to-cell interactions and induced the elevated 
ALP activity (44). It was believed that the mineralization process began at the location where 
ALP was detected in the matrix (45). When the expression of ALP was inhibited, calcification 
would not occur (46). Thereby the increase and expression of ALP was considered one of the 
markers showing that the calcification was occurring (47).  
        Abundant minerals deposits were stained at Day28 in ALG+1%HAP and ALG+2%HAP. 
This was understandable considering the fact that ALP began to express at Day14, which usually 
marked the start of mineralization process. To understand if the HAP particles serve as 
nucleation sites for mineralization during culture, control groups without cells were prepared and 
cultured for 28 days. Results did show the Alizarin red-stained areas, however, not as strong as 
cell-laden samples. This argues that the minerals deposition was mainly from chondrocytes 
rather than the nucleation effect of pre-incorporated HAP particles. 
        Porous composite hydrogel scaffolds were successfully printed by a 3D Bioplotter. Micro-
CT images were obtained to visualize the porous structure and incorporated HAP particles. The 
boundaries of low-density materials like hydrogels seen in micro-CT scans are usually not as 
sharp as high-density materials like PCL (48) or hard tissue due to their lower linear attenuation 
coefficient. This is also the case for segmenting ALG scaffold structural information. When HAP 
was added into the alginate hydrogel, scaffold images could be extracted for morphometric 
analysis. Thus HAP could be used as a contrast agent for low-density materials. A shift of the 
threshold parameters can result in good quality micro-CT image deteriorated by noise and make 
these particles more visible. It can be observed from these images that HAP particles were 
evenly dispersed in the alginate matrix. 
 
5.6 Conclusion 
        This study prepared composite hydrogels consist of ALG and HAP for application in 
calcified cartilage formation. HAP phase was homogenously dispersed within alginate matrices 
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with the addition of SC. The hypothesis that the presence of HAP in alginate hydrogel promotes 
the formation of calcified cartilage matrix including Collagen type X and minerals has been 
tested. The composite hydrogel precursors were successfully printed into porous hydrogel 
scaffolds, showing promising for its application in tissue engineering. These findings 
demonstrate that the ALG/HAP composite is promising for calcified cartilage formation and 
subsequent osteochondral interface regeneration. 
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Chapter 6: Conclusions and Future Work 
6.1 Conclusions 
        Hydrogel, as a water-swollen polymeric network, is attractive as a scaffolding material in 
cartilage tissue engineering. Hydrogels can closely mimic native cartilage ECM and thus provide 
a 3D culture microenvironment favorable for encapsulated chondrocytes. With hydrogels, it is 
also possible to achieve high cell seeding density, homogeneous cell distribution, and transduce 
mechanical stimuli to embedded chondrocytes. However, fabrication of hydrogel scaffolds with 
desired interconnective porosity and living cells is the key issue, which limits hydrogel’s 
applications in CTE. To address this issue, the present study aimed to bioprint porous cell-laden 
hydrogel constructs for application in CTE. This aim was achieved through the following three 
specific objectives.   
        The first objective was to fabricate CTE scaffolds based on the bioprinting technique and to 
study the influence of scaffold design on the mechanical performance. For this, 
thermal/submerged ionic crosslinking process was employed to successfully bioprint porous 
alginate/gelatin hydrogel scaffolds. Six internal structures were designed and printed by varying 
stand orientation and strand spacing. The internal structures were found to play an important role 
in the mechanical properties of printed constructs. This finding provided researchers with a 
convenient way to modulate the mechanical performance of the printed hydrogel scaffolds.  
        The second objective was to develop a 3D bioplotting technique or process supplemented 
with the submerged cross-linking mechanism to fabricate alginate hydrogel constructs with 
living cells. In this regard, a Bioplotting technique supplemented with the submerged cross-
linking mechanism was used to fabricate porous cell-laden alginate hydrogel constructs. In vitro 
biological performance of the printed constructs was evaluated and shown to favor the survival 
and proliferation of embedded chondrocytes, deposition of cartilage ECM including sulfated 
GAG and Collagen type II. 
        The third objective was to test the hypothesis that homogeneously dispersed hydroxyapatite 
in alginate hydrogel promotes the formation of calcified cartilage matrix. For this, by using SC, 
HAP phase was homogeneously dispersed in alginate hydrogel and the presence of HAP 
promoted the formation of calcified cartilage matrix including minerals and Collagen type X. 
Notably, composite hydrogel consists of HAP and alginate demonstrated good printability and 
was successfully printed. 
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        To sum up, a bioprinting technique was developed to fabricate porous cell-laden hydrogel 
constructs. In vitro characterization of the printed constructs has shown to favor embedded 
chondrocytes survival and proliferation, and facilitated deposition of cartilage ECM including 
sulfated GAG and Collagen type II. This bioprinting approach utilized a submerged crosslinking 
process enabling the use of alginate solution with a concentration as low as 2%, which cannot be 
achieved by most other extrusion-based bioprinting techniques. Such a low polymer 
concentration would favor the cells migration and ECM production. Therefore, this bioprinting 
technique is a promising approach for CTE, providing a facile fabrication technique for other 
researchers to produce porous cell-laden hydrogel constructs facilitating cells survival and 
cartilage ECM production from low-viscosity hydrogel precursors.  
        To understand the versatility of the present bioprinting technique, another material-gelatin 
was mixed with alginate and printed. Since gelatin is a type of thermally crosslinkable polymer, 
a thermal crosslinking process was also combined with the submerged ionic crosslinking process. 
Results showed that the present bioprinting technique can be compatible with other crosslinkable 
polymers (e.g. gelatin) and crosslinking mechanisms (e.g. thermal crosslinking). Meanwhile, 
porous alginate/gelatin hydrogel scaffolds with various internal design were successfully printed 
and the mechanical properties of these constructs can be varied by changing internal structure. 
This finding allowed researchers to modify the properties of printed constructs by adding new 
biomaterials or changing the internal structure design.  
        Last, it was shown that the addition of HAP phase into the alginate matrix would promote 
the deposition of Collagen type X and minerals from embedded chondrocytes and thus can be an 
effective design used for calcified cartilage regeneration. This conclusion tested the hypothesis 
that the presence of HAP promotes the secretion of Collagen type X and minerals from 
chondrocytes. The finding showed an easy approach to induce the chondrocytes secrete calcified 
cartilage matrix and this result was consistent with previous finding that by mixing calcium 
phosphate with hydrogels, embedded chondrocytes could potentially produce mineralized 
cartilage matrix. To bring this forward, porous ALG/HAP scaffolds were also fabricated and 
demonstrated promising for use in CTE. In future study, two-layer cell-laden hydrogel constructs 
could be fabricated with upper layer mimicking cartilage and lower layer mimicking calcified 
cartilage. In future study, by printing this two-layer cartilage constructs, we will further test the 
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hypothesis that the calcified layer is required for mechanically-functional osteochondral 
constructs. 
 
        The conclusions drawn from this research and specific objectives that are fulfilled are 
summarized as follows: 
• Bioprinting technique supplemented with a submerged crosslinking process was 
developed to successfully print porous chondrocyte-laden alginate hydrogel scaffolds 
with structural integrity and fidelity; 
• Chondrocytes embedded in printed alginate hydrogel scaffolds were able to survive the 
bioprinting and submerged crosslinking process and the printed chondrocyte-laden 
alginate hydrogel constructs could support cartilage ECM deposition including GAGs 
and Collagen type II, and maintain a good structural integrity throughout the in vitro 
culture period; 
• This present bioprinting technique demonstrated suitability to print other printable bio-
inks (e.g. gelatin) by working with different crosslinking methods (e.g. thermal 
crosslinking). This finding makes it possible to tune the properties by mixing with other 
polymers.     
• By varying the internal architecture parameters, the mechanical properties of the printed 
scaffolds can be tuned. Porosity, contact area between strands and spacing variation 
within printed scaffolds were three key factors that influence the mechanical performance 
of hydrogel scaffolds. 
• With the addition of a surfactant-sodium citrate (SC), a ceramic phase HAP can be 
homogeneously distributed into alginate hydrogel matrix since the SC can negatively 
charge HAP particles and repulsive forces among particles helped to stabilize HAP 
suspension. A critical molar ratio of sodium citrate to HAP was determined as 0.25:1. 
Lower molar ratio than 0.25:1 cannot ensure a long-term homogenous dispersion of HAP 
particles.  
• Chondrocytes mixed in the composite ALG/HAP hydrogel showed a high cell viability 
and synthesized calcified cartilage matrix including Collagen type X and minerals. 
Therefore, the composite hydrogel can potentially be used for calcified cartilage 
formation; 
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• The printability of the composite ALG/HAP hydrogel was verified by successfully 
printing the porous ALG/HAP hydrogel scaffold. Interconnected pore networks and pre-
incorporated HAP particles can be visualized by adjusting the threshold value of 
reconstructed images.  
 
6.2 Future Work 
          Based on the literature review and research results presented in this thesis, some 
recommendations for future research and suggested projects may be conducted in the future: 
• Alginate, as a biocompatible material, possess unique advantages as bio-inks for 
bioprinting such as good printability and rapid crosslinking. However, lack of specific 
adhesion sites of alginate limits its application in tissue engineering. Other bioactive 
hydrogel-forming polymers (gelatin, collagen, and hyaluronic acid etc.) maybe mixed 
with alginate to improve its bioactivity. In this way, the bioactivity from other 
components and the good printability of alginate can be combined to fabricate tissue 
construct with better regeneration outcomes. Chapter 3, as an example, shows the 
possibility of incorporating other materials into the alginate and feasibility of combing 
various crosslinking mechanisms in current bioprinting technique. 
• Growth factors are useful tools to enhance cartilage repair. Insulin-like growth factor 
transforming growth factor-β and bone morphogenetic protein have been shown to 
enhance cartilage formation alone or in combination. The mild conditions of current 
bioprinting process make it possible to include these growth factors in printed tissue 
constructs to stimulate cell proliferation and cartilage ECM deposition. 
• Mechanical stimuli play an important part in the growth and development of articular 
cartilage. Hydrogel can transduce mechanical stimuli to embedded chondrocytes. 
Therefore, a study investigating effect of mechanical stimuli on ECM biosynthesis within 
the printed hydrogel constructs is strongly suggested.    
• New approaches are needed to improve the mechanical properties of current printed 
tissue construct, which are inferior to native cartilage. These approaches may include: 
introducing other polymers into current system, varying the internal architecture, and co-
depositing with thermoplastics et al. 
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• A reason of the poor cartilage self-repair capacity is its low chondrocyte density. 
Harvesting autologous chondrocytes is not an ideal way especially when considering the 
following monolayer cell expansion process may induce de-differentiation and the 
harvesting procedure will leave a donor site. In future study, stem cells may be 
introduced into the present bioprinting system. Stem cells viability, proliferation, and 
differentiation can be investigated in the current bioprinting system. 
• The present study has shown promising cartilage matrix deposition within bioprinted 
constructs for in vitro studies. It is suggested that these printed constructs be implanted in 
animals such as immunodeficient mice, to investigate the structural integrity and long-
term cartilage tissue regeneration of printed hydrogel constructs in vivo. With positive 
results, the functionality of printed hydrogel constructs should be studied to repair 
cartilage defects of articular joints in larger animals, like rabbit and pig, prior to moving 
the stage of applying them to humans. 
 
 
 
